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III. ABSTRACT
Viral  RNA  biogenesis  is  a  crucial  step  in  the  replication  of 
retroviruses that require both the production of a genomic RNA as well 
as  of  translation  templates.  Cellular  and  viral  factors  concur  in  the 
biogenesis of RNA at the specific sub-nuclear chromatin site where the 
reaction takes place. The possibility of tracking viral RNA in living cells 
gives the unique possibility of measuring the kinetic parameters of RNA 
biogenesis as well as defining the dynamic recruitment of host and viral 
factors to the site of replication.
In order to study the activation of HIV-1 gene expression from the 
integrated  viral  promoter  we  exploited  a  method  that  allows  the 
visualization  of  newly  transcribed  RNA  in  living  cells  through  the 
specific  recognition  of  an  RNA  consensus  sequence  for  the 
bacteriophage MS2 coat protein tagged with an autofluorescent protein. 
We observed that transcription of HIV-1 occurred in discrete foci within 
the  nucleus  of  cells  carrying  several  tandem  arrays  of  the  HIV-1 
construct. These foci, representing newly transcribed RNA, co-localized 
with  the  viral  Tat  transactivator  as  well  as  members  of  the  positive 
transcription  elongation  factor  (P-TEFb)  and  RNA  polymerase  II 
(RNAPII). This experimental setting was used to measure the dynamic of 
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HIV-1 RNA transcription in living cells. By fluorescence recovery after 
photobleaching  (FRAP)  we  were  able  to  demonstrate  that  following 
photobleaching  the  process  reaches  a  steady  state  with  a  negligible 
immobile  fraction  allowing  precise  kinetic  measurements  of  RNA 
polymerase  elongation  rates.  We  found  that  elongation  proceeded  at 
approximately  2  kb/min,  and  that  3'-end  formation  and  release  took 
another minute to complete. In addition we also analyzed the dynamic of 
RNAPII  and  the  TAR:Tat:pTEFb  complex  at  the  site  of  HIV-1 
transcription in living cells. Our data suggest that, while the residence 
time of RNAPII exceeds the time required for elongation through the 
viral template, the complex dissociates from the polymerase following 
transcription  initiation,  and  may  undergo  subsequent  cycles  of 
association/dissociation.
This approach was extended to the analysis of single integrated HIV-
1 transcription units by transduction of a HIV-based lentiviral vector into 
a  human cell  line  and subsequent  selection  for  Tat-induction  from a 
latent  state.  Nascent  RNAs from single  integrated transcription units 
were detectable in living cells by MS2 RNA-tagging. At steady state a 
constant  number  of  RNAs  was  measured  at  the  transcription  site 
corresponding  to  a  minimal  density  of  polymerases  with  negligible 
fluctuations over time both in space and intensity of the signal. Recovery 
of  fluorescence  after  photobleaching  of  the  transcription  site  was 
complete  within  seconds,  much  faster  than  what  was  observed 
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previously.  However,  the  necessity  of  taking  into  account  also  the 
diffusion of the tagged MS2 protein required the development of novel 
analytical tools. To this end we developed a model that describes each 
polymerase sliding along the DNA like the peak of a positive progressive 
traveling wave (TranWave) to predict the number of MS2 RNA repeats 
at  the  transcription  site  in  function  of  time.  The  outcome  of  this 
approach and its following improvements are being discussed.
This work provides for the first time a kinetic framework to analyze 
HIV-1 RNA biogenesis and RNA/protein dynamics in living cells.
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The acquired immunodeficiency syndrome (AIDS) is a life threatening 
disease caused by the human immunodeficiency virus type 1 (HIV-1). 
Following its discovery the virus has killed more than 25 million people 
world-wide  and  it  remains  a  major  threat  to  public  health  and  a 
challenge for drug development [Ho and Bieniasz, 2008]. HIV-1 became 
the  most  studied  virus  in  history  and  many  years  of  research  only 
partially unraveled the complexity of its life cycle. Studies on HIV led to 
critical discoveries in antiviral drug development but also gave rise to 
new concepts in viral  and cellular  biology.  However,  the plasticity  of 
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Figure  IV.1:  HIV-1  virion  and 
structure of Gag polyprotein.
HIV-1  Gag  polyprotein  (A)  domain 
structure,  showing  the  locations  of 
MA, CANTD, CACTD, SP1, NC, SP2, 
and  p6.  Schematic  models  of  the 
immature  (B)  and mature (C)  HIV-1 
virions.  Central  slices  through 
tomograms  of  immature  (D)  and 
mature (E) HIV-1 particles derived by 
electroncryotomography.  The 
spherical  virions  are  approximately 
130 nm in diameter [Ganser-Pornillos
et al., 2008].
viral sequences, the establishment of a latent state, and the uncovered 
function of some auxiliary genes still remains a challenge in finding a 
cure for HIV infection [Richman et al., 2009].
IV.1.1 Virion structure
HIV-1 is composed of two copies of a single-stranded RNA enclosed 
by a proteic core (capsid) which is surrounded by the plasma membrane 
(envelope)  of  host-cell  origin  in  which  the  viral  glycoproteins  are 
inserted.  All  structural  proteins,  which  are  components  of  the  HIV-1 
virion, are derived from the Gag polyprotein. Traditionally two forms of 
HIV  particles,  the  immature  form  and  the  mature  form,  have  been 
observed. The immature virion is a roughly spherical shell of radically 
extended uncleaved and multimerized Gag molecules (Fig.  IV.1 B and 
D). During  particle  maturation,  viral  protease  (PR)  is  activated  and 
cleaves Gag generating a set of new proteins and spacer peptides (SP), 
termed  MA,  CA,  SP1,  NC,  SP2  and  p6  (Fig.  IV.1 A).  These  newly 
processed proteins then reassemble to form the distinct layers of the 
mature virion:  MA remains associated with the inner viral  membrane 
(the ‘matrix’ layer), NC coats the viral RNA genome (the ‘nucleocapsid’ 
layer),  and  CA assembles  into  the  conical  capsid  that  surrounds  the 
nucleocapsid and its associated enzymes: reverse transcriptase (RT) and 
integrase (IN) (Fig. IV.1 C and E).
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IV.1.2 Genome organization
HIV-1 is a retrovirus, possessing an RNA genome that is replicated 
via a DNA intermediate. The full HIV genome is encoded on one long 
strand of RNA and contains approximately nine thousand nucleotides. 
HIV has several major genes encoding for structural proteins that are 
found  in  all  retroviruses  and several  nonstructural  (accessory)  genes 
that are unique for HIV. The  gag gene provides structural elements of 
the virus and the  pol provides the replication enzymes. The  Env gene 
codes for glycoproteins which are exposed on the surface of the viral 
envelope.  Accessory  proteins  (Tat,  Rev,  Vif,  Vpr  and  Vpu)  help  to 
enhance virus infectivity.
IV.1.3 HIV-1 life cycle
After entry into a cell the single stranded RNA genome of the virus is 
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Figure IV.2: Structure of the HIV-1 genome and its mRNA products.
The open reading frames for various polypeptides are shown as rectangles. The  
HIV-1  viral  transcript  is  spliced  in  different  ways  yielding  unspliced  (9  kb),  
singly spliced (4 kb) and fully spliced (2 kb) mRNAs. In order to simplify the  
figure only the most important viral proteins are shown [Rahbek, 2008].
reverse transcribed into a double stranded DNA that is transported to 
the nucleus and integrated into the DNA of the host cell as a provirus 
[Greene and Peterlin, 2002]. Integrated provirus is transcribed by the 
host – cell  RNA polymerase II (RNAPII) producing a copy of the viral 
RNA genome that can be used to infect other cells (Fig. IV.3) [Haseltine,
1991]. HIV infects cells of the immune system such as CD4+ T cells and 
cells of the monocyte – macrophage lineage. Productive infection starts 
when HIV-1 fuses its envelope with the cell plasma membrane. Entry is 
mediated by binding of the viral envelope glycoproteins gp120/gp41 to 
the CD4 receptor and to a co-receptor (the chemokine receptors CCR5 
or CXCR4)  [Berger et al., 1999]. These co-receptors provide a critical 
function  for  virus  entry.  CCR5  binds  macrophage-tropic  viruses  (R5 
viruses) and CXCR4 – T cell tropic viruses (X4 viruses). Following fusion, 
the  viral  core  is  released  into  the  cell  cytoplasm.  Immediately  after 
release  into  the  cytoplasm  the  viral  core  undergoes  a  progressive 
disassembly,  known  as  uncoating  and  the  viral  RNA  genome  is 
retrotranscribed  into  double  stranded  DNA  by  the  viral  reverse 
transcriptase.  Finishing  of  reverse  transcription  originates  the  HIV 
preintegration complex (PIC). The viral proteins present in this complex 
are integrase (IN), MA, reverse transcriptase (RT), NC, and Vpr [Farnet
and Haseltine,  1991].  In contrast to most retroviruses, HIV is able to 
infect  nondividing cells  such as differentiated macrophages,  thus PIC 
needs to be translocated into the nucleus.
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To reach the nuclear membrane, the particles must travel through 
the  cytoplasm.  HIV  transport  has  been shown to  exploit  the  cellular 
cytoskeleton. In particular, initial movements at the cell periphery occur 
in association with actin  [Bukrinskaya et al.,  1998], while subsequent 
translocation to the nucleus takes place along the microtubule network, 
likely by interaction of PIC with the dynein-dependent motor complex 
[McDonald  et  al.,  2002].  After  reaching  the  nuclear  envelope  PIC  is 
translocated through  the  nuclear  pore,  most  likely  by  relying  on the 
cellular nuclear import machinery.
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Figure IV.3: Summary of the HIV-1 replication cycle.
After binding and fusing to the surface of the host cell (entry), the 
HIV-1  core  enters  the  host  cell  (uncoating).  Reverse  transcriptase 
synthesizes proviral double-stranded DNA, which is transported to the 
nucleus. Integration occurs and the ensuing provirus expresses viral  
RNA that will synthesize viral proteins.  New virions are created by 
assembly  and  budding  through  the  infected  cell  membrane  and 
subsequent  maturation  due  to  the  actions  of  protease  [Ganser-
Pornillos et al., 2008].
Like  all  retroviruses,  HIV  integrates  into  the  host  chromatin.  The 
process of integration of the linear viral DNA is carried out by the viral 
integrase protein (IN) in coordination with several host cell factor. 
For  a  long  time  integration  of  HIV  and  more  in  general  of  all 
retroviruses was believed to occur randomly into the host chromatin. 
Nevertheless, recent reports have challenged this notion showing a bias 
for  integration  into  transcriptionally  active  genes  [Schroeder  et  al.,
2002].  Moreover,  the  chromatin  status  at  the  site  of  integration 
determines whether the provirus is transcriptionally active, poised for 
activation or inactive. The provirus once integrated into host genome 
can remain transcriptionally inactive, in a latent state or can undergo 
active transcription allowing continuous rounds of infection. After two 
months, in patients on HAART (antiretroviral therapy) the plasma levels 
of  genomic  RNA falls  below the  limit  of  detection.  Therefore,  it  was 
initially assumed that prolonged treatment might lead to eradication of 
the virus  in  these patients  [Marcello,  2006].  Unfortunately,  it  is  now 
clear  that  long-live  reservoirs  of  HIV-1  can  persist  for  years  in  the 
presence  of  HAART.  This  reservoir  is  thought  to  consist  mainly  of 
latently infected resting memory CD4+ T cells  [Chun and Fauci, 1999]
[Pierson et al., 2000]. Both host transcription factors and the viral Tat 
trans-activator have been proposed as limiting factors for transcriptional 
reactivation of latent HIV-1. However, since HIV-1 is found integrated 
into the genome of resting memory T cells, it has been proposed that the 
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chromatin environment at the viral integration site may play a role in 
the transcriptional silencing of the HIV-1 genome  [Jordan et al., 2003]
[Jordan  et  al.,  2001].  Indeed,  integrated  HIV-1  has  nucleosomes 
positioned in its 5’ LTR that are remodeled by deacetylase inhibitors, 
cytokines and Tat  [Lint et al., 1996][Lusic et al., 2003][Marcello et al.,
2004]. Histones play an important role in regulating HIV-1 transcription 
since  they  integrate  signals  for  repression,  like  the  heterochromatin 
marker H3K9 trimethylation, Suv39H1 and HP1, and reactivation, like 
histone acetylation  [Lusic  et  al.,  2003][Chene et al.,  2007].  It  is  now 
clear that also the three-dimensional (3D) nuclear architecture of the 
nucleus could be implicated in HIV-1 provirus regulation, as it has been 
proposed for cellular genes [Misteli, 2007][Dieudonne et al., 2009].
In an infectious state, the integrated provirus is actively transcribed 
from its promoter located in the U3 region of the HIV-1 LTR. Once the 
HIV-1 pre-mRNA transcript is produced, it can be spliced in alternative 
ways to yield three classes of mRNA in the nucleus: unspliced mRNA (9 
kb),  singly  spliced mRNA (4  kb)  and fully  spliced mRNA (2 kb).  The 
three classes of  HIV-1 mRNA and the viral  proteins  they encode are 
shown in Figure  IV.2. All three classes of mRNAs must be exported to 
the cytoplasm and translated into viral proteins for the viral life cycle to 
proceed. The fully spliced mRNAs, which are the first viral transcripts 
that appear after infection, are exported to the cytoplasm. They follow 
the same pathway of cellular RNA [Cullen, 1998] leading to expression 
15
of the regulatory proteins Nef, Tat and Rev. The negative factor (Nef) is 
a modulator of cellular signaling pathways that optimizes the cellular 
environment for virus replication. The transcriptional activator (Tat) up-
regulates  the  synthesis  of  viral  mRNA.  The  regulator  of  viral  gene 
expression (Rev) acts on a post-transcriptional level and plays a main 
role in Rev-dependent export of unspliced and incompletely spliced HIV 
transcripts from the nucleus to the cytoplasm.
The unspliced HIV transcript is the full-length viral RNA which acts 
both as a messenger and genomic RNA. Two copies of genomic RNA are 
encapsidated, usually linked at their 5’ end through the dimer linkage 
site  [Darlix et al., 1990].  Dimerization is associated with encapsidation 
[Greatorex and Lever, 1998], but dimer stabilization occurs post-capture 
by  the  Gag  protein involving  the  NC.  Viral  RNAs  to  be  specifically 
packaged are identified by the presence of an RNA sequence named the 
packaging  signal ( )  placed  within  the  5’leader  ψ [McBride  and
Panganiban, 1996][Berkowitz et al., 1995].
To a first approximation, all the information necessary for retroviral 
particle  assembly  resides  in  the  Gag  polypeptide.  For  example,  Gag 
alone can form extracellular virus-like particles in the absence of other 
viral  proteins  [Gheysen  et  al.,  1989],  and  Gag  molecules  can 
spontaneously assemble into spherical, immature virus-like particles  in 
vitro [Campbell  and Rein,  1999].  All  the  viral  proteins  necessary  for 
virion  assembly  and  RNA  genomes  are  transported  to  the  plasma 
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membranes close to lipid raft membrane domains, where the building of 
new virions begins. The Gag-Pol precursor binds to plasma membrane 
through the myristol group of the MA domain. The resulting virions bud 
from  the  plasma  membrane  but  they  are  still  incomplete.  Their 
maturation  is  finished  by  viral  protease  (PR)  that  cleaves  Gag-Pol. 
Further, Gag and Pol precursors are processed to originate the single 
core proteins, marix and the viral enzymes. The proteolitic activity ends 
when the virion is already detached from plasma membrane and results 
in the formation of mature infectious viruses. 
IV.1.3.1 Accessories  genes
HIV-1 encodes at least nine genes which must be expressed during 
viral life cycle in the correct temporal order. Early in the viral infection, 
small,  multiply  spliced  transcripts  (2  kb)  encoding  Tat,  Rev  and  Nef 
predominate in the cytoplasm. During the late phase of HIV infection, 
genomic (unspliced, 9kb) RNAs and singly spliced RNAs (4 kb) become 
leading species in the infected cell.
Nef
During the replication cycle, other auxiliary proteins of HIV-1 play a 
fundamental  role  in regulating the different  steps of the intrecellular 
viral  pathway.  Completely  spliced  transcripts  encode  for  Nef  that  is 
targeted to the plasma membrane by myristylation of its  N-terminus. 
The  first  studied  activity  of  Nef  is  the  down-regulation  of  the  CD4 
receptor, a mechanism which is supposed to protect infected cell from 
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the  immune system and to  facilitate  the  release  of  HIV-1  virions.  In 
addition  to  CD4,  Nef  is  able  to  promote  the  down-regulation  of  cell 
surface MHC I (major histocompatibility complex 1) that presents viral 
epitopes to cytotoxic lymphocytes (CTL). As consequence, Nef impairs 
the  CTL-mediated  immune  response  that  leads  to  the  lysis  of  HIV-1 
infected cell [Collins et al., 1998].
Vif
The  viral  infectivity  factor  Vif  affects  the  infectivity  but  not  the 
production of viral particles. The protein is encoded from singly spliced 
viral  transcripts  and its  expression is  therefore  Rev-dependent.  Once 
expressed by infected cell, the protein accumulates in the cytoplasm and 
is  found  in  association  with  the  plasma  membrane.  Mutant  viruses 
lacking Vif are less infectious than the wild type, although cell-to-cell 
transmission  is  only  slightly  lower  than  normal.  It  has  been 
demonstrated that Vif promotes the degradation of APOBEC3G [Sheehy
et al.,  2003]. APOBEC3G induces hypermutation in the retroviral plus 
strand DNA, in which up to 25% of all deoxyguanosine (G) sequenced 
are mutated to deoxyadenosine (A). This hypermutation then induces the 
degradation of the viral genome or, in the case of successful reverse 
transcription  and insertion into  the cell  chromatin,  the production  of 
non-functional viral proteins. APOBEC3G restriction is overcome by the 
HIV-1 Vif protein which targets APOBEC3G to ubiquitination and thus 
proteasomal degradation [Sheehy et al., 2003].
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Vpr
Vpr is expressed at later stages of HIV-1 replication and is packaged 
in  all  HIV-1  virions  by  the  p6 core  protein.  After  viral  entry,  Vpr  is 
incorporated  inside  the  PIC  and  enhances  HIV-1  replication  in 
nondividing  cells  by  mediating  its  nuclear  import.  In  addition,  Vpr 
induces  cell  cycle  arrest  in  the  G2  phase  through  the  inhibition  of 
p34cdc2-cyclin B kinase activity increasing virion production [Re et al.,
1995].
Vpu
Vpu is a transmembrane protein unique to HIV-1. Vpu binds to the 
cytoplasmic tail of CD4 and recruits the -TrCP/Skp1p complex at theβ  
level  of  the  endoplasmatic  reticulum.  This  event  induces  the 
ubiquitination  and  the  subsequent  preteosomal  degradation  of  CD4 
while Vpu is recycled. In addition, Vpu enhances release by inducing the 
budding  of  virions  from  the  plasma  membrane  and  promoting  the 
detachment of budding virions [Margottin et al., 1998].
Rev
Rev specifically recognizes an RNA element located within the coding 
sequence  for  Env.  This  sequence,  called  the  RRE  (Rev-responsive 
element),  is  present  within  the  env-coding  region  and  is  about  200 
nucleotides in size and forms secondary RNA structure. Rev binds to this 
region through amino acids in the basic arginine-rich domain [Zapp and
Green, 1989].
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Rev permits export of unspliced/partially spliced transcripts from the 
nucleus to the cytoplasm where they serve as a template for translation 
of  the  gag-pol open reading frame.  On the other  hand the unspliced 
transcript is the full-length genomic RNA which thanks to Rev can be 
translocated to the cytoplasm for encapsidation.
IV.1.4 Tat: structure and function
The  trans-activator protein (Tat)  is  an unusual  transcription factor 
because  it  interacts  with  a  cis-acting  RNA  enhancer  element,  TAR, 
present at the 5’ end of all viral transcripts. The function of Tat has been 
described for the first time by Sodroski et al who noted that synthesis of 
reporter genes placed under the control of the viral long terminal repeat 
(LTR) increased 200- to 300-fold in the cells which have been previously 
infected  by  HIV  [Sodroski  et  al.,  1985].  They  reasoned  that  the 
induction, or “transactivation” of transcription was due to the presence 
of a novel trans – activating factor, which they named Tat.
IV.1.4.1 The structure of Tat protein
Tat is a small nuclear protein of 86 to 101 amino acids (depending on 
the  viral  strain)  which  is  encoded  from  two  separate  exons.  Tat  is 
translated from a group of multiply spliced monocistronic transcripts. 
On  the  basis  of  amino  acids  distribution  in  the  sequence  and  their 
conservation  with  homologous  proteins  from  other  leniviruses,  it  is 
possible to identify five domains. In the first exon (aa 1–72), it can be 
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distinguished  an  N  –  terminal  acidic  domain  (aa  1  –  21);  a  domain 
containing 7 cysteins (aa 22 – 37); a core region (aa 38 – 48); and a basic 
domain (aa 49 – 57) enriched in arginine and lysine amino acids, highly 
conserved  among  different  strains.  In  the  reporter  plasmid  co-
transfection assays, the first 72 amino acids of Tat fully  trans-activate 
transcription  from  the  LTR  [Garcia  et  al.,  1988].  A  basic  domain 
RKKRRQRRR confers TAR RNA-binding properties of Tat  [Dingwall et
al.,  1989][Chang  and  Jeang,  1992] and  is  important  for  nuclear 
localization of the protein [Ruben et al., 1989]. However, studies suggest 
that  this  short  basic  stretch  is  insufficient  in  determining  the  entire 
specificity  of  Tat-TAR binding since amino acids  outside  of  the basic 
domain also contribute to this interaction  [Churcher et al., 1993]. The 
second  coding  exon  of  Tat  has  been  less  studied.  In  the  routine 
transfection of reporter plasmids, absence of the second exon does not 
alter  greatly  measurements  of  Tat  activity  in  this  type  of  assay. 
However,  findings  from  Tat  of  HIV-2  or  SIV  are  quite  clear  in 
demonstrating  that  this  exon  contributes  towards  optimal  trans-
activation [Tong-Starksen et al., 1993].
No  crystal  structure  of  Tat  has  been  obtained  to  date;  structural 
prediction  and  data  from  NMR  spectrometry  [Bayer  et  al.,  1995] 
indicate that the protein has a highly flexible  structure and does not 
exhibit obvious secondary structure elements.
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IV.1.4.2 Role of Tat in HIV-1 transcription
Transcription of the HIV-1 provirus is characterized by an early, Tat-
independent  and a late,  Tat-dependent  phase.  Transcription from the 
HIV-1 LTR is increased several hundred-fold in the presence of Tat and 
the  ability  of  Tat  to  activate  transcription  is  essential  for  virus 
replication.
IV.1.4.2.1 HIV-1 promoter
The U3 region of the HIV-1 LTR functions as the viral promoter. The 
viral  LTR promoter has a structure  typical  of  promoters  activated by 
cellular RNA polymerase II. It contains several binding sites for general 
transcription  factors  as  shown  in  Figure  IV.4.  The  HIV-1  promoter 
contains the core promoter sequence (TATA box) and enhancer elements 
placed upstream and downstream of TATA box. Immediately upstream of 
the TATA box are two tandem NF- B binding sites and three tandem SP–κ
1 binding sites. Immediately downstream of the start of transcription is 
the transactivation response element (TAR). Three tandem binding sites 
for the constitutively expressed Sp1 transcription factor are necessary 
for basal levels of LTR-directed RNA synthesis. Mutation of individual or 
pairs  of  Sp1  sites  has  little,  if  any,  effect  on  the  basal  or  Tat-
transactivated levels of expression [Harrich et al., 1990]. However, the 
mutation of all three Sp1 sites markedly reduces the response to Tat 
[Berkhout and Jeang, 1992]. Two tandemly arranged binding sites ( Bκ  
sites) are recognized by the dimeric transcription factors composed of 
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several  combinations  of  members  of  the  Rel/NF- B  family  ofκ  
polypeptides [Baeuerle and Baltimore, 1996]. The predominant complex 
that  binds  to  the  LTR  B  sites  in  activated  cells  is  NF- B  (p50/p65κ κ  
heterodimer). In unstimulated cells, the p65 subunit of NF- B is retainedκ  
in  the  cytoplasm  through  its  interaction  with  inhibitor  proteins 
belonging to the I B family. The activation of NF- B occurs through theκ κ  
phosphorylation and proteolysis of the I B inhibitor, and the subsequentκ  
translocation of p65 to join p50 in the nucleus where the factor can bind 
to  its  cognate  binding  sites  [Henkel  et  al.,  1993].  Moreover,  the 
arrangement of the transcription factor binding sites in the LTR may 
vary in different HIV-1 subtypes but the specific contribution of these 
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Figure IV.4: . Transcriptional control elements of the HIV-1 5’ LTR.
Schematic representation of HIV-1 LTR promoter with the position of the identified 
binding  sites  for  cellular  transcription  factors.  Factors  binding  to  the  basal  
promoter region are in green, the enhancer is in orange, and upstream sites are in  
blue. The positions of nuc-0 and nuc-1 nucleosomes are indicated. Tat binds to a 
bulge region of a stem-loop structure formed by nascent RNA. The U3, R and U5 
structures of the HIV 5’ LTR are shown [Marcello et al., 2001].
changes has not been yet thoroughly investigated.
IV.1.4.2.2 The Tat – TAR RNA interaction
The transactivation - responsive region (TAR) is located downstream 
of  the initiation site  for  transcription (nucleotides  +1 and +59).  TAR 
RNA sequence forms a highly stable, nuclease – resistant, stem – loop 
structure. The stem – loop structure is located between +19 and +43 
nucleotides which is the minimal sequence for transactivation. Because 
of its location in the R domain of the LTR, TAR is present in both viral 
RNA and DNA.
IV.1.4.2.3 Tat-mediated transcriptional activation
The  interaction  of  Tat  with  TAR  permits  activation  of  HIV-1 
transcription  by  promoting  the  assembly  of  transcriptionally  active 
complexes at the LTR by multiple protein–protein interactions. Over the 
years, a number of cellular proteins have been reported to interact with 
Tat  and  to  mediate  or  modulate  its  activity.  These  include  general 
transcription  factors,  among which are TBP,  TAFII250,  TFIIB,  TFIIH, 
hNAP-1 [Kashanchi et al., 1994][Parada and Roeder, 1996] [Vardabasso
et al.,  2008], RNA polymerase II  [Wu-Baer et al.,  1995]; transcription 
factor Sp1;  the cyclin subunit  of  the positive transcription elongation 
factor  complex  (P-TEFb),  cyclin  T1  [Wei  et  al.,  1998],  and  different 
transcriptional  co-activators  that  possess  histone  acetyltransferase 
activity.  These  interactions  with  P-TEFb  and  HATs  appear  to  be  of 




Cyclin  T1  is  one  of  the  cyclin  subunits  of  P-TEFb  (positive 
transcription  elongation  factor  b)  a  general  elongation  cofactor 
originally identified in D. melanogaster for RNA polymerase II (RNAPII)-
directed transcription  [Price, 2000]. P-TEFb is known to be present in 
the  early  elongation  complexes  and  is  required  for  elongation  after 
promoter clearance. Although the HIV-1 LTR contains DNA binding sites 
for  several  transcription factors,  in  the  absence  of  Tat,  there  is  no 
expression of viral genes. However, there is production of short,  non-
polyadenylated  RNAs  that  include  TAR  RNA.  The  instability  of 
synthesizing  full-length  viral  transcripts  is  caused  by  the  low 
processivity  of  RNAPII,  which  is  overcome  by  P-TEFb.  The  P-TEFb 
complex is composed of one component of the cyclin T family and of the 
cyclin-dependent  kinase  Cdk9.  Cyclin  T1  participates  in  TAR  RNA 
recognition. It has been demonstrated that sequences in the apical loop 
of the TAR RNA are required for cyclin T1 binding [Wei et al., 1998]. 
More  recently  it  has  been  discovered  that  P-TEFb  exists  in  two 
complexes:  large  and  small.  P-TEFb is  inactive  in  the  large  complex 
which additionally contains HEXIM1, hnRNPs and the 7SK small nuclear 
RNA (snRNA).  In response to stimuli  such as stress or  UV light  7SK 
RNA,  as  well  as  HEXIM  proteins  and  hnRNPs  are  released  by  an 
unknown mechanism and P-TEFb is activated forming the small complex 
[Barrandon et al., 2007] [Nguyen et al., 2001].
During the pre-initiation of HIV-1 transcription the carboxy-terminal 
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domain of RNA polymerase II (RNAPII) is phosphorylated by CDK-7, a 
component of TFIIH initiation factor (Fig. IV.5 a). CTD phosphorylation 
is an early step associated with the clearance of the promoter (Fig. IV.5 
b). Following clearance of the promoter, the phosphorylated RNAPII is 
able to transcribe through the TAR region. When the TAR RNA stem-
loop  structure  is  synthesized,  the  Tat  protein  binds  to  it  and  by 
interacting with cyclin T1, activates P-TEFb. The CDK9 kinase present in 
P-TEFb  becomes  constitutively  activated.  The  actvated  P-TEFb 
hyperphosphorylates  the  CTD  domain  of  RNAPII  (Fig.  IV.5 c).  This 
molecular event is associated with increased transcriptional processivity 
(Fig. IV.5 d). The formation of the P-TEFb-TAR-Tat tripartite complex is 
an  essential  step  towards  the  assembly  of  the  processive  RNAPII 
machinery at the LTR promoter  [Bieniasz et al., 1998] [Fujinaga et al.,
1998].
• HATs
The LTR acts as a very strong promoter when analyzed as naked DNA 
in vitro,  but when it  is  integrated into the cellular  genome is  almost 
silent.  Therefore,  chromatin  conformation imposes inhibition onto  the 
integrated promoter [Marzio et al., 1998]. Experiments performed both 
in vivo [Verdin et al., 1993][Kharroubi et al., 1998] and in vitro using the 
HIV promoter reconstituted into chromatin [Sheridan et al., 1997] have 
shown that, independent from the integration site, nucleosomes at the 5’ 
LTR are precisely positioned with respect to the  cis-acting regulatory 
elements  as  shown  in  Figure  IV.4.  In  the  transcriptionally  silent 
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provirus,  these  nucleosomes  define  two large  nucleosome-free  areas, 
one associated with the promoter/enhancer in the U3 region and the 
other spanning the primer-binding site immediately downstream of the 
5’ LTR. These two open regions are separated by a single nucleosome 
called  nuc-1  that  is  specifically  and  rapidly  destabilized  during 
transcriptional  activation.  Complexes  containing  histone 
acetyltransferase (HAT) activity facilitates transcriptional activation by 
modulating  nucleosomal  repression  of  specific  promoters through 
acetylation of the N-terminal tails of histones. This event destabilizes the 
histone-DNA  interaction.  The  HAT  proteins  responsible  for  the  TAR-
dependent Tat transactivation include the transcriptional co-activators 
p300,  the  highly  homologue  cAMP-response  element  binding  protein 
(CREB) binding protein (CBP), the p300/CBP-associated factor (P/CAF), 
the  general  control  non-derepressible-5  (GCN5)  factor,  the  TIP60 
protein, and the general transcription factor TAFII250. Lusic  et al. has 
observed  acetylation  of  histones  H3  and  H4  at  distinct  nucleosomal 
regions  and  the  recruitment  of  mentioned  HATs  to  the  viral  LTR 
promoter upon HIV activation either with Tat or phorbol esters [Lusic et
al., 2003].
The Tat-TAR-P-TEFb interaction which increased the processivity of 
RNA Pol II confirms that Tat plays a role in transcription elongation. The 
initiation model quickly lost support when Kao et al. reported that in the 
absence of Tat the majority of RNA polymerases initiating transcription 
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stall near the promoter  [Kao et al., 1987]. On the other hand it is also 
clear that optimal Tat transactivation of HIV-1 gene expression requires 
upstream transcription co-factors. Along these lines it has been reported 
that  Tat  physically  interacts  with  the  pre-initiation  complex  (PIC) 
including transcription factors such as Sp1  [Jeang et al., 1993], TATA 
binding protein (TBP)  [Majello et al.,  1998], cylinE/cdk2  [Deng et al.,
2002],  TFIIH,  Tip60  [Kamine  et  al.,  1996] and RNAPII  [Cujec  et  al.,
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Figure IV.5: Tat activates HIV-1 transcription.
(a)  The  RNA polymerase  II  (Pol  II)  holoenzyme is  recruited  to  the  HIV LTR 
through  its  interactions  with  TFIID  and  other  components  of  the  basal  
transcription  apparatus.  The  CTD  domain  of  the  RNA  polymerase  is  
phopshorylated  by  the  CDK-7  kinase  found  in  TFIIH  and  the  modified 
polymerase clears the promoter and begins transcription of TAR. (b) The nascent 
RNA chain corresponding to the TAR RNA transcript folds into its characteristic 
stem-loop structure and binds the RNA polymerase. (c) Tat is recruited to the  
transcription  complex  through  binding  to  TAR  RNA  structure  and  forms  a 
ternary complex with TAK (contains CDK-9 kinase and Cyclin T1). The activated 
CDK-9 kinase catalyses phosphorylation of the CTD and TAR is displaced from 
the polymerase. (d) The activated transcription complex is able to transcribe the 
remainder of the HIV genome [Karn, 1999].
1997]. The evidence of Tat interaction with histone acetyltransferases 
support the role of Tat in chromatin remodeling before the onset of viral 
transcription.  It  is  possible  therefore  that  Tat  facilitates  chromatin 
remodeling,  pre-initiation  complex  assembly  and  transcription 
elongation in  the  sequential  manner  that  leads to  high levels  of  HIV 
transcription. All of these activities of Tat are probably exerted by the 
transient  formation of  large subnuclear  complexes at  the site  of  HIV 
transcription and must therefore be spatially and temporally regulated. 
It has been demonstrated [Marcello et al., 2003] that cyclinT1 and p300 
interact with the promyleocytic leukemia (PML) protein within specific 
subnuclear compartments that are coincident with PML nuclear bodies. 
This observation suggests that PML bodies could regulate Tat activity by 
modulating  the  availability  of  essential  factors  to  the  transcriptional 
machinery.
IV.2 Nuclear architecture
The nucleus is a complex organelle with an internal structure and 
component organization that is not fully identified. Understanding the 
molecular details of the organization of the nucleus including: how the 
chromosomes are arranged, how the nuclear compartments are formed 
and maintained, how the synthesis, processing, assembly and transport 
of  molecules  are  coordinated  and  regulated  are  one  of  the  main 
objectives  of  cell  biology.  It  is  well  accepted  that  organization  of 
29
chromatin  is  not  random  and  whole  chromosomes  reside  in  specific 
locations within the nucleus called chromosome territories [Cremer and
Cremer, 2006][Cremer and Cremer, 2006a]. Within the nucleus, protein 
and RNA-protein complexes can move to and from chromatin through 
the interchromatic nucleoplasmic space by a diffusion mechanism until 
they encounter an appropriate binding site. In addition, many nuclear 
factors are able to form or interact with different types of subnuclear 
domains,  which  are  either  attached  to  chromatin  or  located  in  the 
interchromatic space. The nuclear bodies (also called nuclear speckles 
or domains) include nucleoli, splicing speckles, Cajal bodies, gems, PML 
bodies and most recently identified paraspeckles (Fig.  IV.6). They are 
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Figure IV.6:  Nuclear organization.
The nucleus is a complex organelle which contains many specialized 
domains or nuclear sub-structures. Each nuclear domain is a highly  
dynamic structure which is  involved in a certain nuclear process 
[Spector, 2001].
highly dynamic nuclear structures not enclosed by membranes and their 
appearance is probably the result of a tight association of proteins and 
RNA and perhaps DNA components involved in the synthesis, assembly, 
and  storage  of  macromolecules  playing  a  role  in  gene  expression. 
Moreover,  the  exact  maintenance  of  subnuclear  organization  has 
important consequences for cellular function and perturbation of various 
nuclear domains may be associated with disease phenotype.
IV.2.1 Chromosome territories
The  largest  unit  of  organization  of  the  eukaryotic  genome  is  the 
chromosome.  Chromosome  painting  approaches  revealed  that 
chromosomes have preferred positions with respect to the centre or the 
periphery of the nucleus and with respect to each other  [Cremer and
Cremer, 2006]. Thus, the spatial positioning of a  chromosome territory 
(CT) in the nucleus is far from random. A correlation has been observed 
between CT  location  and  human  chromosome  size,  in  which  smaller 
chromosomes  are  generally  situated  towards  the  interior  and  larger 
chromosomes towards the periphery of the nucleus  [Sun et al., 2000]. 
However, there is strong evidence that CTs with similar DNA content, 
but with very different gene densities, occupy distinct nuclear positions. 
This observation indicates that gene content is a key determinant of CT 
positioning.  A striking example comes from the distribution of human 
chromosome  18  and  19.  Although  both  chromosomes  have  a  similar 
DNA content (85 and 67 Mb, respectively), the gene-poor chromosome 
31
18 territories were typically found at the nuclear periphery, whereas the 
gene-rich chromosome 19 territories were located in the nuclear interior 
[Croft et al., 1999]. Genes sometimes move outside of their chromosome 
territory. This relocation occurs either in domains of constitutively high 
gene expression  [Mahy et al., 2002] or, in some situation, when gene 
expression is induced [Volpi et al., 2000]. For example, the  Hoxb gene 
cluster  is  activated  at  the  same  time  as  it  moves  away  from  the 
chromosome  territory  [Chambeyron  and  Bickmore,  2004].  A 
consequence of this relocation is that the ‘looped out’  Hoxb  locus can 
now interact more with other chromosomes. This finding, together with 
the  observation  of  extensive  intermingling  of  DNA  from  different 
chromosomes  at  the  boundary  of,  or  just  outside  of,  chromosome 
territories suggests that chromosome territories might be more dynamic 
then previously thought [Pombo and Branco, 2007].
IV.2.2 Transcription factories
Many  nuclear  processes  are  spatially  compartmentalized. 
Transcription seems to be organized in subnuclear transcription centers, 
also  called  transcription  factories.  Several  thousand  of  distinct 
transcription  sites  appear  to  be  randomly  dispersed  through  the 
nucleoplasm [Wansink et al., 1993]. These transcription sites represent 
hot  spots  of  transcription  that  contain  complex  sets  of  transcription 
factors and polymerases to serve multiple  genes  [Cook, 1999].  It  has 
been  estimated  that  in  the  single  nucleus  there  are  65˙000  active 
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RNAPII molecules but less that 10˙000 trascription sites in HeLa cells. 
Therefore transcription factories would contain 6 -8 actively elongating 
RNAPII that would probably transcribe multiple genes at the same time. 
Analogously,  ribosomal  RNA  genes  which  are  transcribed  by  RNA 
polymerase  I  within  the  nucleolus  represent  large  specialized 
transcription centers. The compartmentalization of transcription has the 
obvious  advantage  of  concentrating  the  needed  factors  to  ensure 
efficient  interactions  among  the  components  of  the  transcription 
machinery. Transcriptionally active genes have been proposed to loop 
out  from their  chromosome territory  and associate with transcription 
factories. Work of Osborne et al. showed that widely separated genes 
are  recruited  to  shared  RNAP  II  sites  if  transcriptionally  active  or 
reposition  away  when  inactive  [Osborne  et  al.,  2004].  They  have 
postulated that genes with transcriptional potential often move out to 
existing  transcription  factories  when  activated  rather  than  assemble 
their  own  transcription  sites  de  novo.  Transcription  units  might  be 
associated through promoters and/or enhancers, with loops forming a 
‘cloud’ around the factory.  Transcription factories are highly dynamic 
structures and involved transient interaction of factors with chromatin 
[Misteli  and Spector, 1998]. Many transcription factors undergo rapid 
exchange  between  chromatin  and  nucleoplasm  and  for  instance  the 
glucocorticoid- and estrogen-receptor transcriptional co-activators bind 
to their specific response elements in the promoter with residence times 
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of only a few seconds [McNally et al., 2000].
IV.3 MS2-based tagging of RNA
Labeling  either  by  fusion  with  a  fluorescent  protein  or  with  a 
fluorescent-dye moiety allows the dynamic study of a protein of interest 
inside  the  cell  in  vivo.  In  the  case  of  nucleic  acids,  intra-molecular 
tagging approaches are required because the target DNA or RNA are 
typically not accessible for tagging in vivo. Labeling of chromosomes in 
vivo can  be  achieved  by  fluorescent  tagging  of  chromosome  binding 
factors.  Usage  of  the  lac  operator  (lacO)  DNA  sequence  which  is 
inserted  into  the  DNA  of  interest  provides  an  elegant  way  to  label 
specific chromatic regions  [Robinett et al.,  1996]. The specific part of 
chromatin can be visualized by expression of a fluorescently tagged lac 
repressor (lacI) fusion protein which specifically binds to lacO sequence. 
This approach has been used to understand the chromosome positioning 
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Figure IV.7: RNA detection MS2-based system.
RNA molecules are detected using a fusion protein that comprises a fluorescent  
tag,  such as  green fluorescent  protein  (GFP)  and the  MS2 bacteriophage coat 
protein. MS2 has an extremely high affinity for a 19 nt RNA-recognition motif that 
is derived from the phage genome [Shav-Tal et al., 2004a].
and movements in living cells  [Janicki et al., 2004]. The mRNA can be 
conjugated to fluorescent dyes and directly microinjected to the cells, 
but  this  is  a  rather  invasive  procedure  [Ainger  et  al.,  1993].  Several 
other  techniques  have  been  developed  which  include  the  use  of 
fluorescently  labeled  probes  for  in  vivo hybridization,  the  use  of 
molecular “beacons” which are active only when bound to target RNA or 
the  use  of  fluorescently  tagged  RNA-binding  proteins  [Politz  et  al.,
1998]. However,  none of those approaches provide information about 
the behavior of a single RNA molecule in real-time in living cells.  An 
innovative approach was developed inserting a series of RNA aptamers– 
stem-loops into the transcript of interest. This RNA is then detected by 
high  affinity  specific  interaction  between  RNA  stem-loops  and 
fluorescently  labeled  bacteriophage  coat  protein  MS2.  Therefore,  the 
RNA  detection  system  is  comprised  of  two  elements,  a  tag 
protein/peptide fused to the MS2 and a reporter RNA containing MS2-
binding  sites  repeated in  tandem.  MS2 binds  specifically  to  an RNA 
stem–loop structure consisting of 19 nucleotides (Fig. IV.7). This method 
allows  to  detect  specific  RNA  in  order  to  study  RNA  dynamics  (i.e. 
biogenesis, processing, export)  in vivo. This technique can be used in 
broad range of applications such as visualization and kinetics of RNA in 
single  cells  by  tagging  MS2  with  a  fluorescent  mark;  or  affinity 
purification and further proteomic studies of endogenously assembled 
RNA-protein complexes in order to identify new factors involved in RNA 
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regulation.
The MS2-based system has been effectively used to tracking specific 
cytoplasmic and nuclear mRNA in yeast, Dictyostelium, plants, flies and 
mammalian cells. For instance MS2-GFP has been used to demonstrate 
that ASH1 mRNA is localized to the bud tip in S. cerevisiae in a zip-code-
dependent  manner  [Bertrand  et  al.,  1998].  Zip-codes  are  cis-acting 
elements  often  placed  in  3’UTRs  of  mRNAs  that  specify  the  spatial 
information for mRNA targeting to a certain subcellular location. Proper 
ASH1  mRNA  targeting  required  the  SHE  protein  complex  which  is 
homologous to mammalian myosin motor proteins. Time-lapse imaging 
revealed that labeled mRNAs move to the bud tip at a rate of 0.2-0.44 
µm/s in a directed fashion [Bertrand et al., 1998]. Using the MS2-system 
in  living  mammalian  cells,  it  was  possible  to  demonstrate  that 
cytoplasmic  mRNAs  exhibit  directed,  corralled,  diffusive  and  static 
movements  [Fusco  et  al.,  2003].  The  -actin  β zip-code  increased  the 
number and persistence of these directed movements relative to a non-
zip-code containing control reporter. Single particle tracking and time-
lapse imaging revealed directed mRNA movements along microtubules 
at an average rate of 1–1.5 µm/s. The MS2-system has also been used for 
the detection and kinetic studies of nuclear events such as transcription 
sites [Janicki et al., 2004]. Visualization and trafficking of single mRNP 
in  the  nucleus  revealed  that  diffusion  is  the  primary  mechanism  by 
which  these  molecules  translocate  from  transcription  site  to  nuclear 
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periphery [Shav-Tal et al., 2004]. The mRNP particles moved an overage 
of 5µm at velocities ranging from 0.03 to 0.08 µm /s. These movements 
were not  affected by metabolic  inhibitors  of active transport  and are 
consistent  with  diffusional  rates.  MS2-based  approaches  allowed  the 
study  of  the  dynamics  of  RNAPII  in  vivo  [Darzacq  et  al.,  2007]. 
Photobleaching and photoactivation of fluorescent MS2 proteins used to 
label  nascent  messenger  RNAs  provided  sensitive  elongation 
measurements. It was shown that RNAPII elongated at 4.3 kb/min on a 
synthetic  gene.  These  data  were  consistent  with  elongation  rates 
measured  on  integrated  HIV-1  genes  [Boireau  et  al.,  2007]. 
Photobleaching of nascent HIV RNAs labeled with MS2-GFP revealed 
that  the  elongation  rate  of  RNAPII  was  approximately  1.9  kb/min. 
Alternatively, the MS2 system can be converted from visualization tool 
to affinity purification coupled with proteomic studies. MS2 fused to the 
maltose binding protein (MBP) has been used to purify the spliceosome 
by  affinity  chromatography  of  cellular  extracts  [Zhou  et  al.,  2002]. 
Thanks  to  this  approach  145  distinct  spliceosomal  proteins  were 
identified, making the spliceosome the most complex cellular machine so 
far characterized.
In conclusion, RNA detection by the MS2 system coupled with live 
cell  imaging  technologies  is  a  powerful  approach  which  allows  the 
analysis of mRNA biogenesis in single cell  in real time. Alternatively, 
MS2  system  coupled  with  high  affinity  chromatography  and  mass 
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spectrometry-based techniques permits  analysis  of  proteome with the 
identification of new components of RNA-protein complexes in vivo.
IV.4 The Green Fluorescent Protein
Green fluorescent  protein  was  discovered  by  Shimomura  et  al.  in 
1962  in  Aequorea jellyfish  as  a  companion  to  the  chemiluminescent 
protein  aequorin  [Shimomura  et  al.,  1962].  Shimomura  et  al.  also 
accurately described the appearance of GFP solutions: “a protein giving 
solution that look slightly greenish in sunlight through only yellowish 
under  tungsten  lights,  and  exhibiting  a  very  bright  greenish 
fluorescence in the ultraviolet  of  a Mineralite”.  In the same year the 
same group showed that the emission spectrum of GFP has a maximum 
at  508  nm  [Johnson  et  al.,  1962].  They  noted  that  the  green 
bioluminiscence  of  living  Aequorea tissue  also  peaked  near  this 
wavelength, whereas the chemiluminescence of pure aequorin was blue 
and peaked near 470 nm, which was 
close to one of the excitation peaks 
of  GFP.  Therefore  the  GFP 
converted  the  blue  emission  of 
aequorin  to  the  green  glow of  the 
intact  cells  and animals.  Morise et 
al. in 1974  purified and crystallized 
GFP,  measured  its  absorbance 
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Figure  IV.8: Two Aequorea victoria GFP 
variants  were  examined  for  their 
different excitation maxima
spectrum and fluorescence quantum yield,  and showed that  aequorin 
could efficiently transfer its luminescence energy to GFP when the two 
were coabsorbed onto cationic support  [Morise et al., 1974]. The first 
estimate for  the monomer molecular weight,  27 kD, was obtained by 
Prendergast  and  Mann  in  1978  [Prendergast  and  Mann,  1978]. 
Fundamental historical landmarks came more than 30 years after the 
discovery  of  GFP,  when  in  1992  Prasher  et  al.  cloned  the  966 
nucleotides long gfp gene [Prasher et al., 1992] and in 1994 Chalfie et 
al. [Chalfie et al., 1994] and Inouye and Tsuji [Inouye and Tsuji, 1994a] 
demonstrated that the protein expressed from this gene is fluorescent 
also in other organisms. Therefore the gene contains all the information 
necessary for the posttranslational synthesis of the chromophore, and no 
jellyfish-specific enzymes are needed [Tsien, 1998a].
IV.4.1 GFP structure and folding
GFP has a unique 11 β-sheet barrel-like structure with a diameter of 
about 24 Å and a height of 42 Å (Fig. IV.9). The β-sheets form the walls 
of a can, and α-helix runs diagonally through the can. The chromophore 
is in the center of the 11 β-sheet and is linked by the  α-helical stretch 
that  runs  through  the  center  of  the  barrel.  The  chromophore,  a  p-
hydroxybenzylidebeimidazolinone,  formed  by  an  intramolecular 
cyclization  of  65Ser-Tyr-Gly67,  is  well  protected in  the  center  of  the 
barrel  [Prasher  et  al.,  1992][Cody  et  al.,  1993].  By  enclosing  the 
chromophore in the can, it may be protected from quenching by oxygen 
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and attack by hydronium ions  [Rao et al., 1980]. The GFP folding into 
the  11-strand  β-barrel  is  probably  the  most  crucial  event  for  the 
formation of the chromophore and its bioluminescence. The formation is 
autocatalytic,  and  the  only  external  requirement  is  the  presence  of 
oxygen  [Chalfie  et  al.,  1994].  The  β-can  structure  protects  the 
chromophore and is presumably responsible for GFP stability [Rao et al.,
1980]. GFP can be reversibly denatured. Fluorescence is completely lost 
in  the  denatured  GFP  but  is  regained  when  the  β-can  structure  is 
reformed  [Ward  and  Bokman,  1982].  The  onset  of  fluorescence  can 
therefore be used as an indicator that the 11-strand  β-barrel has been 
formed.  GFP  fluorescence  is 
not observed until 90 min to 4 
h  after  protein  synthesis 
[Heim  et  al.,  1994].  The 
protein  folds  quickly,  but  the 
subsequent  fluorophore 
formation  and  oxidation  is 
slow [Reid and Flynn, 1997].
IV.4.2 GFP optimizations and spectral variants
Aequorea is  found  in  the  cold  Pacific  Northwest,  and  mature 
fluorescent GFP is most efficiently formed at temperatures well below 
37 °C [Zimmer, 2002]. This has limited the uses of GFP and has led to 
the  search  for  mutants  that  mature  more  efficiently  at  higher 
40
Figure  IV.9:  Stereoview  of  three-dimensional  
structure of GFP [Ormoe et al., 1996].
temperature. Mutation of Phe64 to Leu results in improved maturation 
of fluorescence at 37 °C that is almost equivalent to maturation at 28 °C 
[Cormack et al., 1996].
Several  modification  were  made  to  the  original  GFP  to  make  it 
suitable for  mammalian system,.  The optimization of codon usage for 
mammalian  expression  has  also  improved  overall  brightness  of  GFP 
expressed  in  mammalian  cells  [Yang  et  al.,  1996].  Over  190  silent 
mutations  were  introduced  into  the  coding  sequence  to  optimize 
expression  in  human  tissues.  A  Kozak  translation  initiation  was  also 
introduced by insertion of a Val as the second amino acid [Kozak, 1989]. 
These improvements have resulted in a very useful probe for live cell 
imaging of mammalian cells and are common to all of the currently used 
FPs derived from Aequorea GFP [Goldman and Spector, 2005].
Although  spectral  variants  with  blue,  cyan  and  yellowish-green 
emissions  have been successfully  generated from the  Aequorea GFP, 
none exhibit emission maxima longer than 529 nm. The currently known 
GFP variants may be divided into seven classes based on the distinctive 
components of their chromophores [Tsien, 1998][Zimmer, 2002]:
1. Wild-type GFP. The chromophore is in an equilibrium between the 
phenol and phenolate form. It has a major excitation peaks at 395 
nm and a minor peak at 475 nm.
2. Phenolate anion (EGFP). Ser65 has been substituted with Thr, Ala, 
or Gly. Does not have the 395 nm excitation peak.
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3. Neutral  phenol  (Sapphire). Mutation  of  Thr203  to  Ile  almost 
suppresses the 475 nm excitation peak, leaving only the shorter 
wavelength peak at 399 nm. The emission peak is at 511 nm.
4. Phenolate  anion  with  stacked  π-electron  system  (yellow 
fluorescent proteins). Mutation of Thr203 to His, Trp, Phe or Tyr 
results in yellow fluorescent proteins. The YFPs have the most red-
shifted absorption of all GFP mutant. YFPs have lower fluorescent 
quantum yield than GFPs, especially when excited at 475 nm.
An  enhanced  YFP  mutant,  the  E2GFP,  has  been  obtained  that 
might be used as a single-biomolecule optical switch. As in most 
GFP  molecules,  prolonged  or  intense  excitation,  for  E2GFP  at 
476nm, results in photobleaching. However, in E2GFP irradiation 
of the dark photobleached state at 350nm forms an excited state 
that photoconverts to a form which is fluorescent  [Cinelli  et al.,
2001].
5. Indole  in  chomophore  derived  from  Y66W  (cyan  fluorescent 
proteins). Substitution  of  Trp  for  Tyr66  produces  a  new 
chromophore  with  an  indole  instead  of  a  phenol  or  phenolate. 
Excitation  and  emission  wavelength  are  436  and  476  nm, 
intermediate  between  neutral  phenol  and  anionic  phenolate 
chromophore. These protein are called cyan fluorescent proteins 
(CFPs) because their blue-green or cyan emission.
6. Imidazole  in  chromophore  derived from Y66H (blue  fluorescent 
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protein). Substitution of His for Tyr 66 shifts the wavelength yet 
shorter than Trp66. The excitation and emission peaks are around 
383 and 447 nm, then the emission is blue. BFP suffers from a 
relatively low fluorescence quantum yield and is relatively easily 
bleached.
7. Phenyl  in  chromophore  derived  from  Y66F. The  shortest 
wavelength are obtained with Phe at 66.
The absorbance and fluorescent properties of the different classes are 
summarized in Table 1.
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Mutation Common name λexc [nm] λem  [nm]
Class 1, wild-ype
None or Q80R Wild Type 395-397 504
470-475
F99S, M153T, V163A Cycle 3 397 506
475
Class 2, phenolate anion
S65T 489 509-511
F64L, S65T EGFP 488 507-509
F64L, S65T, V163A 488 511
S65T, S72A, N149K, M153, I167T Emerald 487 509
Class 3, neutral phenol
S20F, T203I H9 399 511
T203I, S72A, Y145F H9-40 399 511
Class 4, phenolate anion with stacked -electron system (YFP)
S65G, S72A, T203F 512 522
S65G, S72A, T203H 508 518
S65G, V68L, Q69K, S72A, T203Y 10C Q69K 516 529
S65G, V68L, S72A, T203Y 10C 514 527
S65G, S72A, K79R, T203Y Topaz 514 527
Class 5, indole in chromophore (cyan fluorescent proteins)
Y66W 436
Y66W, N146I, M153T, V163A W7 434 476
452 505
F64L, S65T, Y66W, N146I, M153T, 
V163A
W1B or ECFP 434 476
452 505
S65A, Y66W, S72A, N146I, M153T, 
V163A
W1C 435 495
Class 6, imidazole in chromophore (blue fluorescent proteins)
Y66H BFP 384 448
Y66H,Y145F P4-3 382 446
F64L, Y66H, Y145F EBFP 380-383 440-447
Class 7, phenyl in chromophore
Y66F 360 442
Table 1: Sprectral characterisitcs of the major classes of green fluorescent proteins 
[Tsien, 1998]. exc and em are the peak of the excitation and emission spectrum,λ λ  
respectively, in units of nanometers
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IV.4.2.1 Fluorescent proteins not from Aequorea
The  discovery  of  novel  GFP-like  proteins  from  Anthozoa have 
significantly  expanded  the  range  of  colors  available  for  cell  biology 
applications.  Despite  the modest  degree of  sequence similarity,  these 
GFP-like  proteins  probably  share  a  β-can  fold  structure  that  is 
fundamental for the fluorescence of GFP. Proteins that fluoresce at red 
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Figure IV.10: Wild-type fluorescent proteins and their spectral variants.
Phylogeny (a) and excitation (b) emission (c) specta of  fluorescent  proteins.  Colors  
indicate emission maxima [Miyawaki et al., 2003].
or far-red wavelengths (red fluorescent proteins or RFPs) are of specific 
interest because they can be used in combination with other fluorescent 
protein that fluoresce at shorter wavelength for both multicolor labeling 
and  fluorescence  resonance  energy  transfer  (FRET)  experiment 
[Miyawaki et al., 2003].
IV.4.3 Applications
Fluorescent  protein are quite  versatile  and have been successfully 
employed  in  almost  every  biological  discipline  to  investigate  a 
remarkable array of properties and behaviors.
IV.4.3.1 Reporter gene
The first applications of GFP were as a reporter gene [Chalfie et al.,
1994]. Gene expression can be monitored by using a  gfp gene that is 
under control of a promoter of interest and measuring during time the 
GFP fluorescence which directly indicates the gene expression level in 
living cells or tissue [Zimmer, 2002].
IV.4.3.2 Fusion Tags
The most  successful  and numerous  applications  of  the  GFPs  have 
been  as  genetic  fusion  partner  to  host  protein  to  monitor  their 
localization and fate. The gene encoding the GFP is fused in frame with 
the gene encoding the protein of interest and the resulting chimera are 
expressed in the cell or organism. Indeed GFP fusion fusion tags can be 
used  to  visualize  dynamic  cellular  events  and  to  monitor  protein 
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localization. GFP has been targeted successfully to almost every major 
organelle of the cell, including plasma membrane, nucleus, endoplasmic 
reticulum,  Golgi  apparatus,  secretory  vesicles,  mitochondria, 
peroxisomes, vacuoles and phagosomes (reviewed in [Tsien, 1998]).
IV.4.3.3 FRET
Fluorescence  resonance  energy  transfer  (FRET)  is  a  nonradiative 
exchange of energy from an excited donor fluorophore to an acceptor 
fluorophore that is within 10-100 Å from the donor. In order for FRET to 
occur,  the  emission  spectrum  of  the  donor  has  to  overlap  with  the 
excitation  spectrum  of  the  acceptor.  The  FRET  efficiency  rapidly 
decreases  with increasing distance between the two fluorophore,  the 
efficiency  is  inversely  proportional  nearly  to  the  sixth  power  of  the 
distance.  FRET  is  a  powerful  technique  for  studying  protein-protein 
interactions in vitro and in vivo  [Marcello et al., 2001][Marcello et al.,
2003][Pantano et al., 2006].
IV.4.3.4 pH sensor
Wild-type  GFP  and  many  of  its  mutant  display  pH-dependent 
fluorescent behavior and have been used to monitor pH in vivo [Wachter
et al., 1997]. A series of pH-sensitive GFP mutant have been developed 
by structure-direct combinatorial mutagenesis; they are often know as 
pHluorins [Miesenboeck et al., 1998].
IV.4.3.5 Photobleaching and photoactivation
Photobleaching and photoactivation when combined with time-lapse 
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imaging can be used to investigate protein dynamics in living cells by 
making its movement observable. Photobleaching is the photo-induced 
alteration  of  a  fluorophore  that  extinguishes  its  fluorescence. 
Photoactivation works by converting molecules to a fluorescent state by 
using  a  brief  pulse  of  high-intensity  irradiation.  After  fluorescently 
highlighting specific populations of molecules can be followed as they 
re-equilibrate in the cell. The extent and rate at which this occurs can be 
quantified and used with computer-modeling approaches to describe the 
kinetic parameters of a protein [Lippincott-Schwartz et al., 2003].
IV.4.3.5.1 Photoconversion
An important  phenomenon,  relevant  either  in phobleaching and in 
FRET measurements, is the photoconversion of YFP in CFP-like-species 
after  photobleaching  [Valentin  et  al.,  2005].  This  process  initially 
controversial  [Thaler et al., 2006] has been later confirmed  [Kirber et
al., 2007].
IV.5 Fluorescence Recovery After Photobleaching
Fluorescence recovery after photobleaching (FRAP) is a method for 
measuring  the  bi-dimensional  or  three-dimensional  mobility  of 
fluorescent particles. A defined portion of the system containing mobile 
fluorescent  molecules is exposed to a brief  and intense focused laser 
beam,  thereby  causing  irreversible,  or  almost  irreversible, 
photochemical  bleaching  of  the  fluorophore  in  that  region.  The 
48
subsequent  kinetics  of  fluorescence  recovery  in  the  bleached  region, 
which  results  from transport  of  fluorophore  into  bleached  area  from 
unirradiated  parts  of  the  system,  provides  a  quantitative  measure  of 
fluorophore mobility [Axelrod et al., 1976].
The  use  of  GFP,  and  principally  of  its  engineered  mutants  with 
improved  brightness,  photostability  and  expression  properties,  as 
minimally  invasive  tool,  allows  the  study  of  protein  dynamics  and 
function in vivo. Cells that express protein tagged with these GFPs can 
be imaged with low light  intensity  over many hours and can provide 
useful information about changes in protein localization and steady-state 
level over time. Time-lapse imaging alone, however, cannot reveal some 
of the arguably most interesting and informative features of proteins, 
their kinetic properties. FRAP is able to investigate the protein kinetic 
that underlie protein function within cells.
Before the bleach the concentration of fluorescent protein should be 
in  equilibrium,  at  the  bleach  there  isn't  any  change  in  physical  or 
chemical properties of the protein tagged with the fluorophore, but the 
tagged protein amount is divided in two families, one set is dark and the 
other is still  fluorescent. This artificial gradient of fluorescent protein 
concentration,  that  is  not  a  true  protein  of  interest  concentration 
gradient, drives the rescue of the equilibrium by diffusion. Analysis of 
fluorescence recovery can be used to determine the kinetic parameters 
of a protein, including its diffusion constant, mobile fraction, transport 
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rate  or  binding/dissociation  rate  from  other  proteins  [Lippincott-
Schwartz  et  al.,  2003].  When  binding  interactions  are  present,  they 
retard a FRAP recovery in relation to what would be observed if only 
diffusion  occurred.  Indeed  a  bleached  protein  have  to  unbound  its 
binding site before to be free to leave the bleached area. Usually GFP is 
considerate a good standard marker of mobility in absence of binding. 
GFP  diffusion  constant  were  estimated  to  be  about  20  µm²/s  in 
cytoplasm or nucleus [Sprague and McNally, 2005].
IV.5.1 FRAP model
In order to obtain quantitative informations from FRAP experiments, 
it is fundamental to develop a robust analysis of the physical phenomena 
involved.  Diffusion  and  reaction,  coupled  or  not,  are  the  principal 
process of the fluorescence recovery after photobleaching.
IV.5.1.1 Diffusion
Diffusion is the net transport of molecules from a region of higher 
concentration to one of lower concentration, as a result of their kinetic 
energy of random motion. There will be a net flow of molecules due to 
the molecular motion only when there is a nonuniform distribution of the 
molecules, otherwise all the molecular motions would average to give no 
net  flow.  In  a  FRAP  experiment  the  bleach  produces  a  nonuniform 
distribution of the fluorescent proteins that riequilibrate by diffusion.
IV.5.1.1.1 Fick's laws
The  first  Fick's  law  (Equation  1)  relates  the  diffusive  flux  of 
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molecules/proteins,  J,  to the concentration gradient,  ∇f.  It  defines the 
diffusion coefficient, D, as the proportionality constant between flux and 
concentration gradient. 
The minus sign in the formula reflects that the diffusive flux goes 
from  higher  concentration  to  lower  concentration  regions.  In  ideal 
conditions the Stoke-Einstein equation, D=kBT/(6πηR), where kB is the 
Boltzmann constant, T the absolute temperature, η the medium viscosity 
and R the radius of the molecules, predicts the diffusion coefficient for 
spherical  or  pseudo-spherical  molecules.  This  relationship  along  with 
the rough approximation that the molecule radius is proportional to the 
cubic  root  of  the  molecule  mass,  possibly  estimate  the  ratio  of  the 
diffusion coefficients of two specie,  a and b, only in function of their 
mass, Da/Db=(Mb/Ma)⅓.
The second Fick's law (Equation 2), or diffusion equation, that can be 
derived from the first law for mass conservation, describes how diffusion 
affects concentration in time. The diffusion equations have been solved 
for FRAP with a uniform rectangular or circular bleach profile and also 
with a Gaussian-shaped bleach profile,  including  one,  two and three-












[Braeckmans et al., 2003].  Three-dimensional solutions of the diffusion 
equation has been proposed  for a Gaussian-shaped bleach profile  or 
taking into account diffusion during bleach [Braga et al., 2004] or based 
on multiphoton excitation [Mazza et al., 2008].
Equation  3 is  a  closed  form  diffusion  equation  solution  in  two 
dimension  and  for  a  circular  uniformly  bleached  spot  in  an  infinite 
domain, involving modified Bessel functions [Sprague et al., 2004].
This equation describe how the fluorescence in the circular bleached 
area, frap(t), evolves after the bleach. In the formula τD=w²/D, where w 
is  the  bleached  area  radius  and D is  the  diffusion  coefficient  of  the 
fluorescent specie. 
IV.5.1.2 Reaction-Diffusion
A general binding reaction can be represented as equation 4, where 
F is the free protein, S the vacant binding site, C the bound complex and 
Kon and Koff are the on and off binding rates. In order to describe the 
reaction-diffusion  behavior  is  necessary  to  link  the  reaction  equation 
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(Equation  4) with the diffusion equation (Equation  2), as in equations 
system 5 [Sprague et al., 2004].
In  the  reaction-diffusion  equations  system (Equation  5)  f,  s  and c 
represent the concentration of free protein, of vacant binding sites and 
of  bound  complexes  respectively;  Df,  Ds and  Dc are  the  diffusion 
coefficient of the free protein, of the binding sites and of the complexes 
respectively. 
Two  assumptions,  applicable  in  many  biological  situations,  can 
considerably simplify this equations system[Sprague et al., 2004]. 
The  first  simplifying  assumption  is  that  the  biological  system has 
reached equilibrium before photobleaching.  This  means that the total 
amount of both fluorescent fusion protein and its binding sites remains 
constant over the time course of the fluorescence recovery. Therefore it 
is possible to assume that the system is at the equilibrium and denote 
the corresponding equilibrium concentrations of F, S, and C by Feq, Seq, 
and Ceq.  Although the act of bleaching changes the number of visible 
free and complexed molecules (F or C), it does not change the number of 
free  binding  sites.  Therefore  s=Seq is  a  constant  throughout  the 
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photobleaching  recovery.  This  eliminates  the  second  equation  of  the 
equations system 5 and also makes possible to replace the variable s in 
the remaining two equation with a constant Seq. As a result, it is possible 
define a pseudo-first-order rate constant given by KonSeq=K*on.
The second simplifying assumption is that the binding sites are part 
of a large, relatively immobile complex, at least on the time- and length-
scale  of  the  FRAP  measurement.  Ignoring  diffusion  of  the  bound 
complex results in Dc=0 in the equations system 5.
With these two assumptions, equations system 5 reduce to equations 
system 6 [Sprague et al., 2004].
The measured FRAP recovery data are the sum of free and bound 
fluorescence, averaged over the bleach spot: frap(t)=avg[f(t)]+avg[c(t)]. 
Normalize the FRAP recovery as in equation 7 to the initial equilibrium 
condition is equivalent to fix that Feq+Ceq=1. 
In equation 7 I(t) is the average intensity of the region of interest at 
time point t,  I(t0)  is  the average pre-bleach intensity of the region of 
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interest  and  T(t0)  and  T(t)  are  the  average  total  area  fluorescence 
intensities  at  pre-bleach  or  at  time  point  t,  respectively  [Phair  and
Misteli,  2000]. This expression accounts for the loss in total  intensity 
caused by the scanning and the bleach itself. The consequence of either 
this normalization and the equilibrium condition in equations system 7, 
∂f/∂t=∂c/∂t=0, allow to obtain the value of  Feqand Ceq (Equation 8).
A solution for the reaction-diffusion equations system (Equation 6) in 
2 dimension and for an uniform circular bleach spot was proposed by 
Sprague  et  al.  in  2004.  Equation  9 is  the  average  of  the  Laplace 
transform of the fluorescent intensity within the bleach spot [Sprague et
al., 2004]; I1 and K1 are modified Bessel functions of the first ans second 
kind. They assume that the binding sites are homogeneously distributed 
and that the bleached spot is small relative to the size of fluorescent 
compartment. The 2D simplification is appropriate when the bleaching 
area  forms  a  near-cylindric  shape  through  the  cell,  as  occurs  for  a 
circular  bleach  spot  of  reasonable  diameter  with  a  relatively  low 
numerical  aperture  objective  [Braeckmans et  al.,  2003].  In this  case, 














component remains [Sprague et al., 2004].
In the same conditions and with the same assumptions Sprague et al. 
propose also a reaction-diffusion model with two independent binding 
interactions [Sprague et al., 2004].
IV.5.1.2.1 Effective diffusion
A simplified  case  for  equations  system  6 arise  when the  reaction 
process is much faster than diffusion. This implies that at any location 
within  the  bleach  spot,  the  binding  reaction  rapidly  achieves  a  local 
equilibrium.  Under  this  condition  the  reaction-diffusion  equations 
system 6 reduce to a simple diffusion equation (Equation 2) but recover 
at a slower rate determined by the strength of binding. In this case it is 
possible to fit the experimental data with equation  3, but the diffusion 
constant measured is an effective diffusion constant, Deff (Equation 10), 
lower than the diffusion constant of the protein in absence of binding, D 
[Sprague et al., 2004].
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Equation 9: Solutions of the reaction-diffusion 
equations system.Solution proposed by Sprague 















q= pDf 1 K on*pKoff 
IV.5.1.2.2 Reaction dominant
Another  simplified  scenario  arises  when  diffusion  is  very  fast 
compared both to  binding and to  timescale  of  the FRAP experiment. 
Free proteins immediately equilibrate after the bleach, so that diffusion 
is not detect in the FRAP recovery. Under this condition the solution of 
the  reaction-diffusion  equations  system  6 reduces  to  equation  11 
[Sprague et al., 2004].
IV.5.1.3 FRAP model optimization
It  is  possible  to  solve  the  reaction-diffusion  system also  with  less 
assumptions.
Beaudouin et al. propose a FRAP three-dimensional model taking into 
account an experimental nonuniform initial distribution of binding sites. 
They solve it numerically using a finite difference approach in a finite 
volume of the dimension of a typical cell nucleus, independently of the 
bleaching geometry [Beaudouin et al., 2006].
Braga et al. and  Kang and Kenworthy solved the reaction-diffusion 
system taking into account that also the complexes can diffuse with a 
specific  diffusion  coefficient  and  solve  the  equations  for  a  Gaussian-
shaped bleach profile in a finite circular domain or in an infinity domain 
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respectively [Braga et al., 2007][Kang and Kenworthy, 2008].
Mueller  et  al.  revisited  the  model  proposed  by  Sprague  et  al. 
[Sprague  et  al.,  2004] and  derived  a  new  FRAP  model,  solving  the 
reaction-diffusion equations system for a Gaussian-shaped bleach profile 
in a finite domain [Mueller et al., 2008].
IV.5.2 FRAP variants
Alternative FRAP methods were developed in order to investigate the 
kinetic properties of proteins of interest in the most advantageous and 
informative conditions [Lippincott-Schwartz et al., 2003].
IV.5.2.1.1 iFRAP
Inverse FRAP (iFRAP) is performed as a normal FRAP experiment but 
in  this  case  the  molecules  outside  the  region  of  interest  are 
photobleached and the loss of fluorescence from the non-photobleached 
region is monitored over time.
IV.5.2.1.2 Photoactivation
A  method  complementary  to  iFRAP  is  the  utilization  of 
photoactivatable fluorescent proteins (PA-GFP), that allow to swich-on 
the fluorescence in a specific region and after follow its reallocation in 
the cell.
IV.5.2.1.3 FLIP
In fluorescence loss in photobleaching (FLIP) technique a fluorescent 
cell is repeatedly photobleached within a small region while the whole 
cell  is  continuously  imaged.  Any  compartment  of  the  cell  that  is 
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connected to the area being bleached will gradually lose fluorescence 
due to movement of mobile bleached proteins from the bleached area to 
the other compartments. By contrast, the fluorescence in unconnected 
regions will not be affected.
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V. RESULTS
To  analyze  the  biogenesis  of  HIV-1  mRNA,  we  developed  two 
different HIV vectors carrying 24 MS2-binding sites: pExo-MS2x24 and 
pIntro-MS2x24  (Fig.  V.1).  In  the  pExo-MS2x24  vector  the  24  MS2 
repeats are in the 3' untranslated region; in the pIntro-MS2x24 vector 
they are within the intron. Each vector has the elements required for 
RNA  production:  the  5'  LTR,  the  major  splice  donor  (SD1),  the 
packaging  signal  ,  the  Rev-responsive  element  (RRE),  the  splice 
acceptor  A7  flanked  by  its  regulatory  sequences  (exonic  splicing 
enhancers and silencers), and the 3' LTR that drives 3'-end formation. 
Moreover  the  pIntro-MS2x24  vector  carries  a  reporter  of  gene 
expression (ECFP) fused to the peroxisome localization signal Ser-Lys-
Leu (skl)  and the  selectable  marker  thymidine  kinase  (TK)  of  herpes 
simplex type 1.
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Figure V.1: p-Exo and P-Into HIV-1 reporters
V.1 pExo-MS2x24 array
Stable arrays of the pExo-MS2x24 construct were integrated in U2OS 
cells  [Molle et al., 2007] [Boireau et al., 2007]. Two clones (Exo1 and 
Exo2)  showed  robust  trans-activation  by  Tat  and  other  stimuli 
(PMA/ionomycin)  known  to 
induce  transcription  of 
integrated  HIV-1  promoters. 
When expressed, the RNAs were 
distributed  homogeneously  in 
the cytoplasm and concentrated 
in  a  bright  spot  in  the 
nucleoplasm.  This  spot 
corresponds to the transcription site as it colocalized with RNA-Poll-II/P-
TEFP  and  was  labeled  with  probes  directed 
against  the  non-transcribed  strand  of  the 
vector  (Fig.  V.2).  To  visualize  nascent  HIV-1 
RNAs,  a  nuclear  MS2-GFP-nls  fusion  protein 
was transiently  expressed in U2OS-Exo1 and 
U2OS-Exo2  cells.  In  live  cells,  MS2-GFP-nls 
was  diffused  in  the  nucleoplasm  and 
concentrated in a spot at the transcription site 
(Fig. V.3).
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Figure  V.3:  Exo1 
transfected  with  MS2-GFP-
nls 
Figure  V.2:  RNA-DNA  and  RNA-PolII 
colocalization at the transcription spot
V.1.1 Kinetic analysis of the transcription site
Fluorescence recovery after photobleaching (FRAP)  [Axelrod et al.,
1976] is  a  powerful  technique  to  study  the  dynamic  properties  of  a 
fluorescent  molecule,  and  we  used  it  to  study  mRNA  synthesis  by 
photobleaching the nascent  RNAs labeled with  MS2-GFP-nls.  When a 
transcription site is bleached, incoming polymerases will synthesize new 
MS2 sites, and this will result in recovery of the fluorescence signal.
V.1.1.1 Transcription Spot
Diffusion of MS2-GFP-nls is rapid (15 µm²/s) and much faster than 
recovery  at  the  transcription 
sites (Fig. V.4). For this reason 
the MS2-GFP-nls diffusion was 
neglected  in  the  analysis  of 
FRAP  experiments.  Recovery 
of  Exo1  transcription  sites 
(Fig.  V.4)  showed  that 
synthesis  of  new  RNAs 
occurred in < 3 min and that 
virtually no RNAs were retained at the transcription site for a long time 
(immobile fraction of  3%).  A second clone expressing the same MS2-
tagged RNA, Exo2, yielded similar kinetics (Fig. V.5), indicating that this 
was principally a property of the reporter. RNA biogenesis occurs in a 
series  of  steps:  transcription,  3'-end  formation  (cleavage  and 
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Figure  V.4:  Exo1  (Black)  and  MS2-GFP-nls 
(Red) recovery curve.
polyadenylation),  and  release 
from  the  transcription  site 
(Fig.  V.6).  To  test  whether 
elongation  was  rate  limiting, 
we  used  a  slow  version  of 
RNA-Pol-II,  the  hC4  mutant 
[Mata  et  al.,  2003].  This  -
amanitin resistant mutant was 
transfected  in  U2OS-Exo1 
cells,  the  endogenous  enzymes  were 
inactivated  with  -amanitin,  and  the 
remaining  transcription  sites  were 
analyzed  by  FRAP.  As  a  control,  we 
used  another  -amanitin 
resistant version of RNA-Pol-
II  that  was  not  defective 
(wild  type  [WTres];  [Mata  et
al.,  2003]).  FRAP  curves 
obtained  with  WTres or  the 
endogenous  polymerase 
were  nearly  identical  (Fig. 
V.7).  In  contrast,  recoveries 
were  markedly  slower  with  the  hC4  mutant:  129  s  for  half-recovery 
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Figure  V.6:  Transcription and RNA 
processing
Figure  V.5:  Exo1  (Black)  and  Exo2  (Red) 
recovery curve.
Figure  V.7:  Exo1 recovery  curve  with  different 
RNAPII.
versus  75  s  for  the  WTres 
enzyme.  To  confirm  that 
transcription elongation took a 
substantial  part  of  the  time 
that  nascent  RNAs  spent  at 
their  transcription  sites,  we 
used  camptothecin.  This  drug 
targets topoisomerase-I, and it 
transiently  cross-links  it  to 
DNA. A previous study has shown that this creates steric road blocks for 
polymerases, which result in increased pausing and a net slowdown of 
transcription  elongation  [Capranico  et  al.,  2007].  Indeed,  when  cells 
were treated with this drug, the recovery of nascent RNA was slower: 
170 s for half-recovery in Exo1 
cells compared with 65 s in the 
case  of  untreated  cells  (Fig. 
V.8). To further establish that 
elongation  was  rate  limiting, 
we developed a cell line, Exo-
long,  wich differed by 2.4  Kb 
in the length of  the sequence 
separating  the  MS2  repeats 
and  the  end  of  the  gene.  If 
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Figure  V.8:  Exo1  (Black)  and  Exo1  with 
Camptothecin (Red) recovery curve.
Figure  V.9:  Exo1  and  Exo-Long  recovery 
cureves.
elongation is rate limiting, the recovery should be slower for the long 
reporter,  and  the  difference  should  represent  the  time  taken  to 
transcribe the additional sequences. As expected, transcription sites of 
Exo-long recovered more slowly: 126 s for half-recovery versus 65 s for 
the  short  reporter  (Fig.  V.9).  Altogether,  these  observations 
demonstrated  that  elongation  took  a  substantial  fraction  of  the  time 
dedicated to mRNA production.
V.1.1.2 A two step model for elongation and 3'-end processing
Transcription elongation is the repetition of an elementary step: the 
transcription of one nucleotide. The stochastic basis of the process, that 
is a typical Poisson process with a constant rate kel, implies that the time 
taken to add a single nucleotide, or the time between two independent 
events,  is  variable  and  follows  an  exponential  distribution.  This 
distribution is described by the rate constant kel and has an expected 
value  of  1/kel.  When  polymerases  transcribe  a  large  number  of 
nucleotides, the repetition of the elementary step creates a statistical 
average such that the time taken to synthesize  n nucleotides  will  be 
virtually  constant  for  all  polymerases  and  equal  to  n/kel.  This 
consideration on the nature of the transcription process allows us to 
predict a linear increase in signal during FRAP recovery. Elongation is 
the first  step of mRNA biogenesis that can be observed in our FRAP 
experiment.  Indeed,  once the  polymerase reaches the PolyA site,  the 
pre-mRNA  is  cleaved,  polyadenylated  and  released.  These  precesses 
65
occur  as  a  series  of  single  steps  and,  thus,  may  be  modeled  as 
exponentials. We attempted to fit the FRAP curve with two components: 
a straight line for elongation followed by a single exponential for 3 -end′  
formation  and  release,  equation  12,  where  telong is  the  time  point  at 
which the line converts to exponential. Since in equation 12 the numbers 
of constants were overestimate we reformulated equation 12 in equation 
13, assuming the continuity of both the function and its first derivative. 
In equation 13 A is the function value at t=0, M the mobile fraction and 
α is the slope of the initial linear component.
This  two-step  model 
(Equation 13) fitted well the 
experimental  data  (Figs. 
V.10 and  V.12).  The  short 
reporter gave 65 to 73 s for 
elongation and 44 to 31 s for 
the  half-time  of  the 
exponential  in  Exo1  and 
Exo2  cells,  respectively 
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Figure V.10: Exo1 two step model fit.
Equation 12: Basic linear plus exponential model
f t={A⋅t , t≤telongBC [1−e− t−telong] ttelong
Equation 13: Linear plus exponential model
f  t={A⋅t , t≤telongA⋅telongM−A−⋅telong [1−e− t−telongM−A−⋅telong ] , ttelong
(Table  2). The long reporter 
yielded 148 s for elongation 
and 65 s for the exponential 
(Fig.  V.11).  This  translated 
into similar elongation rates 
of  1.79–2.03  kb/min.  Cells 
treated  with  camptothecin 
or transfected with the slow 
mutant of RNAPII could also 
be  fitted  to  this  two-step 
model (Figs. V.13 and V.14). 
For  the  hC4  mutant,  it 
yielded  an  elongation  rate 
more  than  twofold  slower 
than  with  WT  RNAPII  (0.8 
kb/min),  which  is  in 
agreement with in vitro data 
[Coulter  and  Greenleaf,
1985]. 
67
Figure V.12: Exo2 two step model fit
Figure V.11: Exo-Long two step model fit.






Length to 3' end [nt] 2187 2187 2187 4580 2187 2187
Immobile fration [%] 4 5 0 0 0 0
Linear phase [s] 57 161 75 135 71 172
t mean exponential [s] 65 150 43 95 178 83
Elongation rate [Kb/min] 2.3 0.8 1.7 2.0 1.9 0.8
Table 2: Two step model fits results
V.1.1.3 Pol-II 
Although the MS2-GFP FRAP assay provides a direct measurement of 
RNAPII activity, it provides little information on the events that occur 
either before the polymerase reaches the MS2 repeat or after it releases 
its  mRNA.  To  gain  a  complete  view  of  the  transcription  cycle,  we 
repeated the FRAP assay with fluorescent  subunits  of  RNAPII.  HIV-1 
transcription  sites  were  identified  with  a  red  variant  of  MS2  (MS2-
mCherry),  and GFP-tagged subunit  C of  RNAPII  was bleached in the 
nucleoplasm or  at  HIV-1 transcription  sites.  Recoveries  at  the  HIV-1 
transcription site were much slower than in the nucleoplasm, suggesting 
that most polymerases present at the HIV-1 gene array were engaged in 
transcription (Fig.  V.15). Interestingly, recovery of the polymerase was 
substantially slower than recovery of nascent RNAs: in Exo1 cells, half-
recovery took 200 s for the polymerase but only 66 s for nascent RNAs. 
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Figure V.13: Exo1 Camptothecin. Figure V.14: Exo1 Pol-hC4
To extract more information from the recovery curves, they were fitted 
with the diffusion/reaction model developed by Sprague [Sprague et al.,
2004].  This  model  assumes 
that  the  bleached  spot 
contains  identical  binding 
sites  that  are  equally 
distributed  in  space,  also 
outside  the  area  of  bleach, 
and  it  allows  to  derive 
diffusion  coefficients, 
binding  time  (b),  and  the 
delay  between  two  binding 
events (d). Although probably oversimplifying we applied this model to 
describe our system. Indeed at the equilibrium/steady-state we have a 
cluster of immobile binding sites in an homogeneous compartment, the 
nucleoplasm.  The  recovery  curves  obtained  with  the  subunit  C  of 
RNAPII  were  fitted  with  a  reaction  dominant  version  of  this  model 
(Equation  11). In Exo1 cells, we found that the polymerase resided for 
333 s  at  the  HIV-1 transcription  site  and diffused for  10 min before 
engaging a second transcription cycle. When the residency time of the 
polymerase was compared with that of  nascent RNAs, it  was obvious 
that the polymerase remained on the gene longer than expected. From 
the fit of Exo1 recovery curve with the two-step model, we know that 
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Figure  V.15:  RNAPII  recovey  curve  at  the 
transcription spot (Black) and in the nucleoplasm 
(Green).
The red line is the reaction dominant fit.
elongating through the reporter should take 114 s, and 3' end formation 
should take 63 s. Indeed, if the length of the full reporter is 3.852 Kb, it 
will take 114 s to transcribe it at a rate of 2 Kb/min. Thus, the difference 
between the total residence time of the polymerase at the transcription 
site, 333 s, and the time needed in transcription, 114 s, plus that for the 
3' end formation, 63 s, is 156 s. Because chromatin immunoprecipitation 
experiments demonstrate that RNA-PolII stops rapidly after the end of 
the gene and is released without preceding much through neighboring 
sequences  [Boireau et al., 2007], it is reasonable to suppose that this 
156 s are employed at the transcription initiation step.
V.1.2 TAR:Tat:P-TEFb complex at HIV transcription sites
To evaluate the dynamic properties of the TAR:Tat:P-TEFb complex 
we identified HIV-1 transcription sites with a yellow or red fluorescent 
variant of MS2, and performed photobleaching experiments on CFP and 
GFP-tagged  versions  of  Tat  and 
Cdk9 (Figs.  V.16 and  V.17). When 
Tat or Cdk9 were bleached in the 
nucleoplasm  of  U2OS  cells,  the 
fluorescence  recovered  quickly, 
indicating  that  these  proteins 
diffused  rapidly  through  the 
nucleoplasm.  We  then  bleach  Tat 
and  Cdk9  at  the  HIV-1 
70
Figure  V.16:  MS2  and  Tat  at  the 
transcription spot
Figure  V.17:  MS2  and  CDK9  at  the 
transcription spot
transcription  site,  to  analyze  the  dynamic  properties  of  the  complex 
formed on nascent RNAs.
V.1.2.1 Tat and Cdk9
The turn-over of  Tat  was slow,  as  complete  fluorescence  recovery 
took nearly three minutes. We observed two contrasting situations in the 
recovery curve of Cdk9 depending on the mode of activation of the HIV-
1 promoter. In the presence of Tat, Cdk9 recovery was also slow and 
took  several  minutes  to  go  to  completion.  In  contrast,  when  HIV-1 
transcription  was  activated  by  PMA/ionomycin,  Cdk9  was  highly 
dynamic,  and  recovery  was  within  seconds.  Tat  and  Cdk9  recovery 
curves  were  analyzed  with  the  diffusion/binding  model  proposed  by 
Sprague and MacNally (Equation  9)  [Sprague et al.,  2004],  assuming 
that our conditions could be approximated to those of the model, and 
results are summarized in table 3.
D [µm²/s] τb [s] τd [s]
Tat 8 55 60
Cdk9/Tat 7 71 142
Cdk9/PMA-ionomycin 9 11 15
Table 3: Kinetic parameters of the fitted Tat/Cdk9 FRAP curves.
D is the diffusion coefficient, τb the binding time and τd the time between two binding 
events.
The diffusion coefficients calculated for Tat and Cdk9 were similar 
and small,  although they differed substantially  in mass,  pointing to a 
complex containing both protein. We found that Tat remained bound to 
nascent HIV-1 RNAs for 55 seconds, τb ,  and diffused for 60 seconds 
between two binding events, τd. Similarly, in the presence of Tat, Cdk9 
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resided for 71 seconds at HIV-1 transcription sites, but diffused for 142 
seconds  between  two  binding  events.  This  situation  changed 
dramatically  when  HIV-1  was  activated  by  PMA/ionomycin,  in  the 
absence of Tat. In this case, PTEFb turn-over was rapid, as it remained 
bound to the HIV-1 transcription site for only 11s. Since PMA/ionomycin 
promotes transcription by activating NF-kB, which directly recruits P-
TEFb, a major conclusion of this work is that the dynamic properties of 
P-TEFb depend on its mode of recruitment to the HIV-1 promoter. It is 
interesting to speculate that the higher stability of the Tat:TAR:P-TEFb 
complex may account for the stronger activation obtained with Tat. A 
similar case has been observed for the transcription factor HSF (heat 
shock factor) in Drosophila [Yao et al., 2006]. Indeed, while HSF bound 
its target gene whether it is activated or not, the dynamic properties of 
this interaction varied dramatically upon transcriptional activation. This 
raises  the  possibility  that  it  is  not  only  the  binding  of  transcription 
factors  to  their  target  genes  regulates  transcription,  but  also  the 
dynamic properties of these events. 
V.2 pIntro-MS2x24 single integration
In order to study HIV-1 transcription in a system more similar to the 
natural viral infection condition, we developed a cell line carrying not an 
array but a single integration of the pIntro-MS2x24 construct (Fig. V.1). 
The HOS_A4 and HOS_B3 clones  showed a robust  and homogeneous 
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induction of the ECF-skl reporter in the cytoplasm upon treatment with 
GST-Tat  [De  Marco  et  al.,  2008][Dieudonne  et  al.,  2009].  After 
activation,  the  RNAs  were  concentrated  in 
one  (A4)  or  two  (B3)  bright  spots  in  the 
nucleoplasm  (Figs  V.18 and  V.19).  When 
HOS_A4  or  HOS_B3  were  transfected  with 
EYFP-MS2-nls  and  the  virus  transactivator 
Tat  tagged  with  mDsRed 
many  ECFP  peroxisomes 
appeared  in  the  cytoplasm 
and a bright yellow spot was 
clearly visible in the nucleus. 
This spot is compatible with 
a  single  site  of  pIntro-
MS2x24  transcription  that 
co-localized  with  Tat-
mDsRed  (Fig.  V.20). 
Immunofluorescence  with  antisera  against  CyclinT1,  the  P-TEFb 
component  recruited  directly  by  Tat  on  the  viral  RNA,  or  RNAPII, 
demonstrated enrichment of such factors at these sites (Fig. V.21). 
V.2.1 Kinetic analysis of the transcription site
We investigated the  kinetic  property  of  the  pIntro-MS2-24x  single 
integration transcription site by FRAP, as we did for the pExo-MS2-24x 
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Figure V.20: HOS_A4
Figure V.21: HOS_A4 CyclinT1and RNA PolII
Figure  V.19: 
HOS_A4 RNA 
FISH




V.2.1.1 Transcription activation 
When  the  pIntro-MS2-24x  cells  were  activated  by  transient 
transfection of the viral transactivator Tat, the transcription of the pro-
virus  was  constant  for  more  than  10  hours  (Figs  V.22 and  V.23) 
maintaining  peripheral  localization  [Dieudonne  et  al.,  2009].  The 
observation that the transcription spot intensity was constant over time 
suggests that also the RNA amount at that place was constant in time. 
Indeed, if the RNA amount at the transcription site is constant, when the 
system  is  perturbed  by  FRAP,  any  observed  variation  on  the 
transcription spot fluorescence intensity can not be intrinsic but must be 
generated by the bleach input.
V.2.1.2 Transcription spot
Surprising the recovery of fluorescence at the transcription spot for 
the single pIntro integration was very different as compared with that 
observed for the pExo array. The recovery of the single pIntro has an 
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Figure V.22: Spot at 30min Figure V.23: Spot at 16h
half recovery time of almost 1 
s compared to the 65 s needed 
for  the  pExo array  (Fig  V.4). 
Clearly  in  this  case  it  is 
impossible  to  neglect  the 
effect of diffusion, because the 
two processes have the same 
time scale recovery (Fig V.24). 
In  order  to  estimate  the 
transcription rate also for the 
pIntro single integration, it is therefore necessary to develop a model 
able to take into account both transcription and MS2-EYFP-nls diffusion.
We treated pIntro-MS2-24x cells with several transcription inhibitors, 
with different inhibition mechanism, as DRB, actinomycin-D, -amanitin, 
camptothecin  and  flavopiridol,  and  we  always  observed  the  fast 
disappearance of the spot. Although, if it was possible in the pExo array 
to  slow  down the  fluorescence  recovery  at  the  transcription  spot  by 
inhibiting  transcription  with  a  drug  (Fig.  V.8),  in  the  pIntro  single 
integration cells we could not measure any slowing down in recovery 
rate. Until  the spot was detectable, the rate of fluorescence recovery 
was unaffected and the recovery curve was indistinguishable from the 
control.
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Figure  V.24:  B3  Clone,  Ms2-YFP-nls  at  the 
transcription  spot  (black)  and  in  the 
nucleoplasm (blue).
V.3 Transcription waves model
We developed a model to predict the number of MS2 RNA repeats at 
the transcription site in function of time. 
We built our model on two assumptions:
1. all polymerases have the same transcription rate;
2. polymerases are equidistant.
We describe each polymerase sliding along the DNA like the peak of 
a positive progressive traveling wave (Equation  14). The transcription 
rate is the propagation speed (ω/k in equation 14), the maxima velocity. 
The  amplitude  of  this  wave  is  the  number  of  MS2  RNA  repeats 
transcribed by the single polymerase. This amplitude (Equation  15) is 
modulated  following  the  position  of  the  polymerase  on  the  DNA: 
increases linearly during transcription of the 24 MS2 RNA repeats (l1 in 
equation 15), is constant until the enzyme reaches the splicing acceptor 
site  or  the  polyadenilation  site  (l2 in  equation  15),  when  the  RNA 
processing begins and then exponentially decays (Fig. V.25). The model 
provides many important  parameters  of  the system: the transcription 
rate, the polymerases density (π/k, equation 14) and the RNA processing 
mean life (k/(ωα), equations 14 and 15). The total number of MS2 RNA 
repeats at the transcription spot is the sum of the peak values (Equation 
16).
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Equation 14: Progressive wave.
f x ,t=A x⋅∣cosk⋅x−⋅t∣
At the equilibrium the total number of RNAs at the transcription site 
is  constant,  with  polymerases  sliding  along  the  DNA  and  the 
transcription  of  new  RNAs  is 
compensated by the processing 
of  that  already  transcribed. 
When we perturb the system by 
bleaching  the  transcription 
spot,  the  MS2-EYFP  protein 
bound to the RNA repeats loses 
its  fluorescence  but  newly 
synthesized  repeats  are  freely 
accessible to fluorescent MS2-EYFP. The speed of fluorescence recovery 
at the transcription spot is related both to the rate of transcription and 
to that of RNA processing. Indeed, in order to recover the fluorescence 
signal  at  the  transcription  spot,  new  repeats  have  to  be  produced 
because the mean life of the binding of MS2 protein to the MS2 RNA 
77
Figure V.25: Transcription Wave model.
Equation 15: Transcription wave 
amplitude.
A x={24l1 ⋅x ∀x≤l124 ∀x≤l2
24⋅e−x−l2 ∀xl2











repeats is many time higher 
than  the  recovery  of  the 
spot. It is also clear that, in 
order  to  rescue  the  initial 
fluorescence  value,  all  the 
bleached  MS2-EYFP 
proteins,  bound to the MS2 
RNA repeats,  have to leave 
the  transcription  site.  We 
initially tested the TranWave 
model by fitting the recovery curve data of U2OS-Exo1 carrying an array 
of integration sites, with equation 16 (Fig. V.26). The transcription rate 
obtained (2.4 Kb/min) was very similar to that obtained with the linear 
plus exponential model discussed previously (2.3 Kb/min). Also the time 
needed  for  the  RNA  processing  obtained  from  the  two  models  are 
compatible,  65  and  73  s,  respectively.  The  transcription  wave model 
allows also to estimate the PolymeraseII density at the transcription site, 
almost one each 100 bp.
V.3.1 Transcription Wave and Diffusion
In order to measure the recovery of the signal at the transcription 
site, after the bleach, the fluorescent MS2-EYFP proteins have to diffuse 
inside the area of bleach. The transcription spot can recover its intensity 
only if new fluorescent proteins are free to bind it. 
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Figure V.26: Exo1 Transcription Wave fit.
Three  different  scenarios  are  possible:  diffusion  is  faster  than 
transcription, transcription is faster than diffusion or transcription and 
diffusion have the same time scale. 
If diffusion is faster than transcription (ie. pExo-MS2x24 and pIntro-
MS2x24  array),  after  the  bleach  free  fluorescent  MS2-YFP  protein 
immediately diffuse at the transcription site before new RNA repeats are 
produced,  and the  recovery  of  the  intensity  of  the  transcription  spot 
follows exactly the RNA production.
If  transcription is  faster than diffusion,  after  the bleach new RNA 
repeats  are  synthesized  at  the  transcription  site  before  fluorescent 
protein  can  bind  to  it,  therefore  only  after  MS2-EYFP  diffusion  it 
becomes  possible  to  measure  recovery  at  the  spot.  In  this  case  the 
recovery of fluorescence at the transcription site would rise like that of 
MS2-EYFP diffusion. However, it is difficult to imagine that transcription 
can be faster than diffusion.
If  transcription  and  diffusion  have  the  same  time  scale  both  the 
processes participate to the recovery of the spot intensity.
When diffusion is faster than transcription, it is possible to take into 
account the effect of diffusion on the recovery of the transcription spot 
with  a  new  assumption:  the  diffusion  of  MS2-EYFP  protein  is  not 
influenced by the presence of the MS2 RNA repeats. This assumption is 
reasonable when the MS2 molecules free to bind are many time more 
abundant that their specific RNA binding sites. In this conditions we can 
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predict  the  concentration  of  free  MS2-EYFP at  the  transcription  site 
assuming  that  the  protein  diffuse  within  this  region  like  in  the 
nucleoplasm. We modified the equation  9 proposed by Sprague et al. 
[Sprague et al., 2004] integrating the solution of the reaction diffusion 
system for the free subset, not in a circle with the same radius of the 
bleached spot, w, but in a circle with a smaller radius, w0. We used this 
equation (Equation.  17) to predict the concentration of MS2-EYFP-nls 
free  to  bind  at  the  transcription  spot.  The  solution  for  the  total 
fluorescence  in  a  smaller  radius  was  used  as  a  background  of  our 
measurements (Equation. 18).
Introducing this last assumption we are able to distinguish the two 
components  of  the  fluorescence  recovery  at  the  transcription  spot 
(Equation  19),  diffusion  of  the  MS2  protein  and  transcription.  The 
parameters necessary to predict the diffusion of MS2, equations 17 and 
18,  were  independently  obtained  by  FRAP  experiments  in  the 
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Equation 18: Modified solution of the reaction-diffusion 
equations system for the total fluorescence in a circle of 


















Equation 17: Modified solutions of the 
reaction-diffusion equations system for 
the free subset of fluorescent protein 








nucleoplasm outside the transcription spot. In equation 19: MS2(t) is, as 
in  equation  18,  the  background  of  fluorescence,  MS2free(t)  is,  from 
equation  17,  the  portion  of  fluorescent  MS2  free  to  bind  the  RNA 
repeats at the transcription spot, and finally TranWave(t), as equation 
16,  is  the  number  in  time  of  MS2  RNA  repeats;  MS2,  MS2free and 
TranWave are the equilibrium values. The parameters obtained from the 
experimental  data fitted by equation  19 are all  those involved in the 
transcription wave model, as described in paragraph V.3, plus α, that is 
a weight for the fluorescence background at the transcription spot.
V.3.2 pExo/pIntro-MS2x24 array
Since the single integration cell line carry the pIntro construct, we 
decided to develop a cell line with an array of pIntro similarly to what 
was done for pExo for direct comparison of the two models (arrays  vs 
single integration). The fluorescence recovery at the transcription site of 
the pIntro-MS2x24 array, U2OS-pIntro, is similar to that of U2OS-pExo 
(Figs. V.27 and V.28). We applied equation 20 to fit FRAP data from the 
U2OS-pExo and U2OS-pIntro transcription spots (Figs.  V.27 and V.28); 
this equation fits well the experimental data and results are summarized 
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TS arrays: ω [1/s] k [1/bp] ρ [Kb/min] α [1/bp] β [1/bp] τ [s]
PolII 
[n/bp] n MS2
pExo 6.2·10-1 1.6·10-2 2.3 1.5·10-4 / 173 191 1000
pIntro 6.4·10-1 4.5·10-2 0.9 5·10-4 2·10-3 176 70 1300
Table 4: pExo/pIntro array transcription wave model results.
The  transcription  rate  value  obtained  for  U2OS-pExo,  ρ, is  in 
agreement  with  that  obtained  with  the  previous  model,  linear  plus 
exponential (table 2).
In  order  to  fit  data  from  the  pIntro  construct  we  introduced  an 
additional  variable  to  the  transcription  wave  model,  β,  to  take  into 
account  that  in  this  case  RNA  degradation  can  start  just  after  the 
splicing acceptor site and not only at the polyadenilation site. In this 
case the transcription rate was lower than what measured for U2OS-
pExo, but still in the same order of magnitude.
V.3.3 pIntro-MS2x24 single integration
When  we  applied  the  transcription  wave  model  as  formulated  in 
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Figure V.27: pEXO Figure V.28: pIntro
equation  19 to  fit  the  recovery  curve  of  the  Intro-MS2x24  single 
integration, HOS-Intro, we were unable to obtain a reasonable value for 
the  variables.  Indeed  we 
obtained  a  transcription  rate 
of 25 kb/min and 15 RNAPII at 
the  transcription  spot  (Fig. 
V.29).  We  supposed  that  the 
model  failed  because  the 
assumption on the MS2-EYFP 
diffusion  was  not  respected 
being  influenced  by  the 
presence  of  RNA  specific  binding  sites  at  the  transcription  spot. 
Transcription spot fluorescence recovery in HOS_A4 or HOS_B3 is very 
fast,  and has the same time scale of diffusion.  It  is  possible that just 
after the bleach the number of available RNA repeats is major than that 
of MS2-EYFP free to bind it. Perhaps it is also important to considerate 
that  the  local  concentration  of  MS2-EYFP  bleached  at  the  first  time 
points after the bleach is higher than that of still  fluorescent protein. 
Indeed at the beginning of fluorescence recovery some MS2-EYFP in the 
dark stage can bind the repeats introducing a variation from the model.
V.4 Monte Carlo simulation
Since  the  reaction-diffusion  equations  system  (Equation  6)  is  not 
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Figure V.29 B3 Transcription Wave Model
analytically resolved for both clusterized and unstable/growing in time 
binding sites, we decided to reformulate our transcription wave model, 
equation  19, by replacing the diffusion component, obtained modifying 
the  Sprague  solution  (Equations  17 and  18),  with  a  Monte  Carlo 
simulation. This approach allows us to reduce the model assumptions 
and  to  take  into  account  effects  previously  neglected.  With  a  Monte 
Carlo simulation it  is  possible to calculate the deviation on the MS2-
EYFP-nls diffusion made by the RNA repeats at the transcription spot. 
This  method  also  allows  to  take  into  account  the  probability  that 
bleached MS2-EYFPs can bind the new synthesized RNA repeats at the 
first time steps after the bleach, when their local concentration is higher 
respect the still fluorescent protein subset.
We developed a two dimensions Monte Carlo system in a matrix and 
we fixed the cell dimensions as that of our FRAP experiment pictures 
pixel. The dimension of the matrix was chosen to have the same area of 
a typical cell nucleus. Fixing the cell length, the diffusion coefficient is 
uniquely determinate from the time step, as in equation 20.
We validated our  Monte  Carlo  system simulating  the MS2-YFP-nls 












experimental  recovery  curve  with  the  Sprague  model,  equation  10. 
Indeed we fitted the simulated curve with the same equation and we 
obtained parameters pretty similar to that used to run the Monte Carlo 
simulation (Fig. V.30).
The next implementation to 
definitely  tackle  the 
transcription  rate 
measurement  in  the  single 
integration pIntro cell line will 
be  linking  the  Monte  Carlo 
simulation  with  the 
Transcription Wave model.
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Figure V.30: Monte Carlo simulation fitted with 
the Sprague model.
VI. DISCUSSION
Transcription  by  RNA polymerase  II  (RNAPII)  is  the  process  that 
translates DNA into RNA leading to the expression of a specific gene in 
mammalian cells. The core of the process is the polymerizing activity of 
RNAPII that chemically catalyzes the addition of nucleotides to the RNA 
chain. Since transcription occurs in the environment of the living cells it 
became to be important to measure the transcription rates in such a 
context.  However,  very  few  studies  were  able  to  measure  directly 
RNAPII activity in  vivo. In vitro kinetic analysis of human RNAPII have 
yielded elongation rates between 0.9 and 1.8 kb/min and have suggested 
that the chemical step is rate limiting  [Burton et al., 2005]. The giant 
gene of human dystrophin and the long (8 kb) yeast nonessential gene 
YLR454, have also been used to evaluate elongation rates [Tennyson et
al., 1995][Mason and Struhl, 2005]. These studies yielded values of 2.4 
and  2  kb/min,  respectively.  The  range  of  observed  elongation  rates 
values in different biological  systems went from 1.5 kb/min for living 
bacteria to 5.7 kb/min for eukaryotic ribosomal RNA genes [Dundr et al.,
2002][Golding et al., 2005].
Several groups used the RNA reporter system that employs the coat 
protein  of  phage  MS2  fused  to  the  green  fluorescent  protein  (GFP) 
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[Bertrand et al., 1998]. It was possible to monitor dynamics of mRNAs in 
a living cell by inserting of several MS2 binding sites in an inducible 
reporter gene [Shav-Tal et al., 2004a][Golding and Cox, 2004][Le et al.,
2005][Forrest et al., 2003].
To analyze the biogenesis of mRNA in live cells and real time, we 
engineered  cell  lines  that  contained  many  copies  of  the  reporter,  a 
construct based on the human immunedeficiency virus 1 (HIV-1) (Figure 
V.1), integrated in a single place within the chromatin (75 copies for 
Exo1 cells).  This  amplifies  the  signal  such that  many events  become 
visible by microscopy analysis [Janicki et al., 2004].
In our system we measured elongation rates of RNAPII, by bleaching 
MS2-GFP-nls bound to nascent RNAs, obtaining an elongation rate of 
approximately 2 kb min-1 and no evidence of exceeding pausing of the 
polymerase  [Boireau et al.,  2007](Fig.  V.11). Three important controls 
support our result (Table  2). First, increasing the length of the mRNA 
increased the total synthesis time but yielded a similar elongation rate 
(Fig.  V.14).  Second,  a  slow  mutant  of  RNAPII  induced  a  reduced 
transcription rate (Fig. V.10). Third, treating cells with camptothecin, an 
inhibitor  of  elongation,  also  reduced the  rate  of  RNA synthesis  (Fig. 
V.12). In our analysis we neglected the possibility of a rapid dissociation 
of the RNA-bound MS2GFP-nls that may lead to rapid recovery rates 
unrelated  to  the  synthesis  of  new RNAs.  This  issue  was  resolved  by 
measuring  the  recovery  of  fluorescence  on  a  relatively  immobile 
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nucleolar  RNA (U3)  carrying  an MS2 binding  site  (Fig.  VII.1).It  was 
shown that the recovery of  bound MS2 on U3 exceeded ten minutes 
indicating a high affinity of the protein for the substrate in agreement 
with in vitro studies on the RNA binding properties of the MS2 protein 
[Johansson et al., 1998].
Interestingly in a similar system, carrying 100 tandem integrations of 
reporter, RNAPII was estimated to elongate at 4.3 kb min-1 with long 
paused intervals [Darzacq et al., 2007]. In vitro single-molecule analyses 
of  bacterial  RNA  polymerases  have  shown  that  the  time  taken  to 
transcribe  a  DNA segment  can  vary  substantially  between individual 
molecules,  and  at  least  part  of  this  variability  can  be  attributed  to 
polymerase  pausing  [Herbert  et  al.,  2006].  In  higher  eukaryotes, 
pausing  is  also  a  well-known  phenomenon,  and  there  are  some 
evidences  that  the  RNAPII  elongation  rate  affects  gene  expression 
[Batsche et al., 2006]. However, as showed in paragraph V.1.1.2, where 
we  presented  our  two  step  model,  we  described  elongation  as  the 
repetition of an elementary step and represented it as a straight line in 
the  recovery  curves  (Fig.  V.11).  This  does  not  take  into  account  the 
polymerase  heterogeneity  that  can  be  caused  by  pausing  that  may 
directly contribute to the exponential component of the curve. Although 
in many cases determining polymerase pausing time could not be easy, 
it seems that pausing occurs when cells were treated with camptothecin. 
Indeed,  in  this  case,  the  MS2-GFP-nls  FRAP  assay  indicated  a  large 
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increase in the exponential component of the recovery curve (Fig. V.12). 
Because camptothecin is believed to physically arrest the polymerase, it 
is tempting to speculate that this increase represents pausing.
We  studied  also  RNAPII  kinetic  at  the  transcription  site  and  the 
polymerase recovery curves were fitted with a diffusion-binding model 
(Fig.  V.15). The results were compared with that obtained for nascent 
RNAs  bleaching.  The  data  indicated  that  during  the  333s  that  the 
polymerase  resided  at  the  HIV-1  transcription  site,  114s  could  be 
attributed  to  elongation,  and  65s  could  be  attributed  to  3'-end 
processing and transcription release. The remaining 154s could be the 
result  of  initiation  and  termination.  This  long  residence  time  of  the 
polymerase  can  be  explained  by  several  alternative  hypothesis.  It  is 
possible that the polymerase would reengage transcription on the same 
gene  by  a  looping  mechanism,  as  described  for  yeast  [Ansari  and
Hampsey, 2005][O'Sullivan et al., 2004] and also for HIV [Perkins et al.,
2008]. Looping brings physically together the 5' and 3' ends of a gene 
coupling  initiation  with  termination.  Alternatively,  as  a  result  of  the 
tandem array of integrations, RNAPII is not released from the DNA after 
termination sliding on the following template in the array. However, this 
hypothesis  is  unlikely  given the  observation  by CHIP assays  that  the 
density of RNAPII on the HIV gene decrease after termination [Boireau
et  al.,  2007].  One  could  imagine,  however,  that  RNAPII,  after 
termination  and  release,  remains  in  the  area  able  to  reinitiate  the 
89
following  gene.  Finally  we  can  not  exclude  that  some  polymerases 
present at the HIV-1 transcription sites are stalled or are involved in as 
yet  uncharacterized  but  slow  processes.  As  described  in  paragraph 
V.1.1.3, we found that although the residency time of the polymerase at 
the  HIV-1  gene  was  333  s,  the  diffusion  time  between  two  binding 
events was 10 min. Previous FRAP experiments of the large subunit of 
RNAPII at random nucleoplasmic sites have indicated that for cellular 
genes, polymerases should spend only a third of their time engaged in 
transcription [Kimura et al., 2002]. Because the half-life of transcription 
was estimated as 20 min,  it  was deduced that polymerases spend as 
much as 90 min diffusing between two transcriptional cycles [Kimura et
al., 2002]. Thus, the initiation at the HIV-1 promoter is nearly 10 times 
more frequent than at cellular genes. This could be caused by a high 
efficiency of transcription initiation at the HIV-1 site or, alternatively, by 
a much higher density of active genes at the HIV-1 transcription site, 
although  also  in  this  case  it  is  not  possible  to  exclude  a  tandem 
integration effect. Interestingly, we did not detect a rapid component in 
the  recovery  curves  of  RNAPII,  which  corresponds  to  polymerases 
undergoing rapid binding and dissociation from the promoter  [Darzacq
et  al.,  2007].  In  contrast,  the  vast  majority  of  polymerases  appeared 
transiently immobilized on the HIV-1 gene and engaged in productive 
transcription.  This suggested that the initiation of HIV-1 transcription 
was  indeed  very  efficient.  A  high  efficiency  of  initiation  would  be 
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consistent with the biochemical studies that have shown that the HIV-1 
promoter is constantly occupied by the polymerase [Jeang et al., 1999]
[Marcello et al., 2001].
The integration of several independent transcription units increases 
the sensibility of our system and gives the possibility to visualize and 
study the recruitment of factors such as the Tat/P-TEFb complex at the 
HIV-1 transcription site (Figs. V.16 and V.17). Our data showed that Tat 
and P-TEFb remained bound to nascent RNAs for about a minute (Figs. 
V.26 andV.25,  Table  3).  If  HIV-1  transcription  proceeds  with  the 
previously  described  rate  of  2  kb/min,  then  elongation  through  our 
reporter RNA would last more than 2 minutes. This raises the possibility 
that  the  TAR:Tat:P-TEFb complex  is  dissociated  from the  polymerase 
before the gene is completely transcribed. Following dissociation,  the 
fate of Tat and Cdk9 is likely to differ,  as shown by their  significant 
difference in the time between two binding events (τd in  Table 3). It is 
remarkable that Tat and Cdk9 have very similar dynamics. This supports 
the idea that they remain together in the elongating complex, rather 
then Tat being transferred to the polymerase while P-TEFb dissociating 
from it. Since chromatin immunoprecipitation data have shown that Tat 
and P-TEFb are present with elongating polymerases all along the gene 
[Bres  et  al.,  2005],  we  suggest  that  Tat  and  P-TEFb  could  undergo 
constant association and dissociation cycles with TAR and the elongating 
polymerase.  Altogether,  our  data  showed  that  the  TAR:Tat:P-TEFb 
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complex is remodeled during HIV-1 transcription.
Results discussed so far relied on the insertion of tandem arrays of 
the  constructs,  approximately  75  copies  [Boireau  et  al.,  2007],  and 
almost 100 copies in a similar work  [Darzacq et al.,  2007], that is an 
artificial situation that has also been shown to induce heterochromatin 
at  the  repeats  site  [Wang  et  al.,  2006].  Therefore,  such  pioneering 
studies could only open the way to further analysis to be carried out on 
single  genes.  Among retroviruses,  the human immunedeficiency  virus 
type 1 (HIV-1) maintains a robust transcription in the presence of the 
viral Tat transactivator possibly allowing the production of enough RNA 
to  be  visible  by  MS2-tagging.  Hence,  we  decided  to  exploit  HIV-1 
derived vectors carrying all  cis- information for packaging, integration 
and Tat-inducible transcription plus the MS2 binding sites inserted in 
the  intron  downstream  of  the  major  splice  donor  (Figure  V.1). 
Transduced  HOS  cells  were  selected  to  be  inducible  by  the  viral 
transactivator and to carry single integrations of the vector. The HOS-B3 
and HOS-A4 cell clones were chosen for subsequent work (Figures V.20 
and V.21). 
First  we  analyzed  the  intensity  of  the  EYFP-MS2nls  signal 
continuously in HOS_B3 live cells after transfection of Tat and EYFP-
MS2-nls. As shown in figure  V.22, little variation was observed in the 
intensity associated with the transcription sites for 30’. The bursts or 
pulses observed in other systems  [Chubb et  al.,  2006][Golding et al.,
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2005] were  either  not  detected or extremely  small,  below 1% of  the 
signal. Further analysis up to 17 hours did not show major fluctuations 
either  (Figure  V.23).  Analysis  was  initiated  fifteen  hours  after 
transfection indicating that, when the viral transactivator is not limiting, 
HIV  transcription  is  continuously  active.  This  situation  mimics 
productive  infection  where  the  duration  of  the  HIV  gene  expression 
pulse,  determined  by  the  positive  feedback  loop  of  Tat,  exceeds  the 
lifespan of the infected cell [Weinberger et al., 2005].
Next,  we  wished  to  explore  the  kinetic  behavior  of  HIV  RNA 
biogenesis from a single transcription unit. Therefore, we measured the 
recovery of fluorescent MS2 fusion protein bound to the MS2 stem-loops 
in the HIV RNA after photobleaching the transcription site. As shown in 
figure  V.24, recovery of the signal in HOS_B3 occurred within seconds 
regaining  pre-bleach  equilibrium value  after  almost  10s.  This  finding 
was surprising and totally unexpected after previous observations made 
on tandem arrays that showed recovery at plateau after more than 200s 
[Boireau et al., 2007][Darzacq et al., 2007]. Indeed, when we compared 
directly  the  same  HIV-Intro-MS2×24  construct  either  as  single 
integrated  provirus  or  in  tandem  arrays  (Figs.  V.24 and  V.28),  the 
previous  recovered  ten  times  quicker  than  the  latter.  In  both  cases 
recovery  reached  equilibrium  with  a  negligible  immobile  fraction, 
indicating that no RNA was retained at the transcription site for longer 
times. Furthermore, this was not an intrinsic property of the HOS_B3 
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clone,  since  other  clones  derived  with  the  same  protocol,  like  the 
HOS_A4 clone, showed similar recovery curves.
After the bleaching of the transcription sites, new MS2 binding sites 
are  synthesized  resulting  in  the  recovery  of  the  fluorescent  signal. 
However,  RNA  is  visualized  indirectly  through  MS2-EYFP-nls 
introducing a series of possible uncertainties in the interpretation of the 
FRAP data. Indeed a slow diffusion rate of MS2-EYFP-nls may mask the 
neo-synthesis of nascent RNAs. Diffusion of MS2-EYFP-nls was rapid and 
much faster than the recovery at the transcription sites and therefore 
neglected when measuring tandem arrays [Boireau et al., 2007][Darzacq
et al., 2007]. Also in our case, diffusion of MS2-EYFP-nls didn’t impact 
significantly the recovery of fluorescence in tandem arrays of HIV-Exo-
MS2×24 (Fig.  V.4). However,  when comparing the recovery curve of 
free MS2-EYFP-nls in the nucleoplasm to the recovery of fluorescence at 
the transcription site in HOS_B3 cells the two curves were very close, 
although distinguishable (Fig.  V.24). Hence, diffusion of MS2-EYFP-nls 
in  the  area  of  bleach  cannot  be  neglected  in  the  calculation  of  the 
transcription rate in single HIV transcription units.
We propose a model (TranWave) that describes the kinetic behavior 
of MS2-EYFP-nls binding to newly synthesized RNAs in order to measure 
RNAPII transcription rates. As a first step, in order to predict the kinetic 
of MS2-EYFP-nls at the transcription spot that is available for binding to 
the repeats, we took advantage of the well-described diffusion-binding 
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model proposed by Jim McNally and collaborators [Sprague et al., 2004]. 
With  this  information  we  hypothesized  that  MS2  binding  sites  were 
produced  at  a  certain  rate  in  the  transcription  spot,  dependent  on 
RNAPII activity. The intensity of the fluorescent signal generated by the 
MS2-EYFP-nls  effectively  bound  to  the  RNA at  the  transcription  site 
would be proportional  both to the amount of  free protein and to the 
available  binding  sites.  At  steady  state  there  is  equilibrium  between 
nascent  RNAs  that  is  produced  by  RNAPII  and  its  release  from  the 
transcription  site.  To  predict  this  behavior,  assuming  that  the 
polymerases are equidistant and that the transcription rate of RNAPII is 
constant, we imagined each polymerase trailed along the gene as the 
peak of a harmonic traveling wave. The amplitude of the wave would be 
linearly  increasing during the synthesis  of  the repeats,  then constant 
until  the polymerase reaches signals for  splicing or release from the 
transcription  site  and  then  exponentially  decreasing  (Fig.  V.25 and 
Equation 15). Hence we can measure the transcription rate of RNAPII as 
the propagation speed of the wave, which is the speed of the sliding of 
the wave peak.  In a FRAP experiment the recovery  curve includes a 
component that is  intrinsic  of  the diffusive behavior of  MS2-EYFP-nls 
and a component that depends on the transcription rate of RNAPII, both 
of which are predicted by TranWave. We initially applied TranWave to 
cells carrying tandem arrays of HIV-Intro-MS2×24 and HIV-Exo-MS2x24 
(Fig.  V.1).  We obtained transcription  rates  of  approximately  2  and 1 
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kb/min  respectively  (Table  4),  that  were  comparable  to  what  we 
obtained  with  the  two  step  model  or  what  others  group  reported 
[Darzacq et al.,  2007]. However, when we measured the transcription 
rate of the singularly integrated provirus we obtained the value of  25 
kb/min that exceeds five to ten fold the values measured values so far. 
Interestingly, quantitative FISH showed that the number of RNA MS2 
repeats  presents  at  the  transcription  site  in  the  single  integration  is 
almost  one half  of  that  in  the  array.  This  results  is  surprising  if  we 
consider that in the array there are 49 more copies of the same reporter 
than  in  the  single  integration.  We  can  conclude  that  the  number  of 
RNAPII involved in transcription at the single integration site is higher 
than that of the tandem array. This higher concentration of RNAPII can 
also  partially  explain  the  higher  transcription  efficiency  that  we 
measured.  Indeed  it  has  been  reported   in  bacteria  that  most 
transcriptional  delays  disappear  if  more  than  one   RNA  polymerase 
molecule initiates from the same promoter [Epshtein and Nudler, 2003]
[Epshtein et al., 2003].
However we are still improving our model in order to decrease the 
number  of  assumptions  and  simplifications  and  to  obtain  stable  and 
reliable fits of our experimental data. To this end we are developing a 
Monte Carlo simulation of the diffusion component of recovery curve.
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VII. MATERIAL AND METHODS
The experimental  part  of  this  work  dealing  with  plasmid  and cell 
manipulation, was conducted with the precious help of Anna Knezevich 
and Alex De Marco.
VII.1 Cells and plasmids
VII.1.1 Plasmids
Plasmids expressing MS2-GFP, Tat-eGFP, CDK9-GFP, GFP-CycT1 and 
the hC4 and WTRES mutant of RNAPII have been described previously 
[Mata  et  al.,  2003][Fusco  et  al.,  2003][Marcello  et  al.,  2003].  MS2-
Cherry  and  GFP-PolII-C  were  created  with  the  Gateway  system 
(Invitrogen). U3-MS2 was created by inserting a single MS2 site in the 
apical loop of the rat U3B.7 gene. pExo-MS2×24, pIntro-MS2x24 and 
pExo-MS2×24-Long plasmids  were  derived from the  plasmid  pEV731 
[Jordan et al., 2001][Marcello and Giaretta, 1998].
VII.1.2 pExo and pIntro HIV-1 based cells
U2OS and HOS cells were cultivated at 37°C in DMEM containing 
10% FCS and antibiotics.
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VII.1.2.1 pExo and pIntro-MS2x24 array
Stable  U2OS  transformants  were  obtained  with  the  calcium-
phosphate procedure by cotransfecting a 20-fold excess of the vector of 
interest,  pExo,  pExo-Long  or  pIntro  (Fig.  V.1),  with  Ptk-Hygro  and 
selecting  cells  with  132  g/ml  hygromycin.  Individual  clones  wereμ  
expanded, and their gene copy number was measured by quantitative 
PCR using DNA from U1 cells as reference (two copies per genome). 
U2OS-Exo1,  U2OS-ExoLong  and  U2OS-Intro  contained  approximately 
75, 70 and 50 copies, respectively [Boireau et al., 2007]. 
VII.1.2.2 pIntro-MS2x24 single integration
Osteosarcoma HOS_143b cells, that are negative for tymidine kinase 
activity  (TK-),  were  transduced  with  pIntro-MS2x24 vector  (Fig.  V.1) 
pseudotyped with the VSV-G envelope. To select for clones that carry an 
inducible  integrated provirus,  cells  that  constitutively  expressed high 
level of HSV-TK were selected by treatment with 50 µg/ml ganciclovir. 
Surving cells, that were either non-transduced, or transduced but with a 
low  level  of  TK  expression,  were  treated  with  GST-Tat  and  briefly 
selected for inducible HSV-TK expression in hypoxanthine, aminopterin 
and  thymidine  (HAT)  medium.  Clonal  populations  were  obtained  by 
limiting dilutions and colonies were visually scored for low basal level of 
ECFP expression in the cytoplasm and to be higly inducible by GST-Tat 
by fluorescence microscopy  [De Marco et al., 2008]. The HOS_A4 and 
HOS_B3 clones showed a robust and homogeneous induction of ECF-skl 
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in  the  cytoplasm  upon  treatment  with  GST-Tat.  Southern  blotting 
analysis  and cloning of the integration sites by inverse PCR revealed 
that in HOS_A4 clone a single copy of the provirus integrated in the 
HMBOX1 gene of chromosome 8. HOS_B3 instead carry two single copy 
of the provirus integrated in the SIPA1L2 gene (chromosome 1) and in 
the DOC1 gene (chromosome 3)  [De Marco et al., 2008][Dieudonne et
al., 2009][Biancotto, 2006].
VII.2 Imaging and FRAP procedures
VII.2.1 Microscopes
The DMRA (Leica) wild-filed microscope was equipped with a 100x 
NA 1.4 objective and a CoolSNAP HQ (Roper Scientific) camera and was 
controlled by MetaMorph software (Universal Imaging Corp.).
The DMIRB (Leica) wild-filed microscope was equipped with a 63x 
NA 1.4 objective and a CoolSNAP K4 (Roper Scientific) camera and was 
controlled by MetaMorph software (Universal Imaging Corp.).
The LSM510 META (Zeiss) confocal microscope was equipped with a 
63x NA 1.4 objective.
The Nikon TE200 microscope was equipped for  both confocal  and 
wide-field imaging. A 100x NA 1.45 objective was used. The wide-field 
port was equipped with an EM-CCD (Cascade 512K; Roper Scientific) 
camera controlled by MetaMorph (Universal Imaging Corp.).
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VII.2.2 Immunofluorescence and in situ hybridization
Immunofluorescence  and  in  situ  hybridization  were  performed  as 
previously  described  [Marcello  et  al.,  2003][Fusco  et  al.,  2003]. 
Fluorescent  images  of  fixed  cells  were  captured  with  different 
microscopes,  either  the DMRA and DMIRB (Leica) wide-field  and the 
LSM510 META (Zeiss) confocal microscope.
Stacks  of  wide-field  images  were  deconvolved  with  Huygens 
(Bitplane AG) or with the ImageJ (Rasband, W.S., ImageJ, U. S. National 
Institutes of Health, Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/, 
1997-2009) plug-in “Iterative Deconvolve 3D”.
VII.2.3 Live cell imaging and FRAP experiments
For live cell imaging, cells were maintained at 37°C in appropriate 
medium and humidity  and CO2 air  concentration were under control 
[Fusco et al., 2003].
VII.2.3.1 Wide-field FRAP
Recovery curve showed in figures V.4, V.5, V.7, V.8, V.9, V.10, V.11, 
V.12,  V.13,  V.14,  V.15 and  V.26 were obtained with the Nikon TE200 
microscope. A circle of 2.5µm diameter was bleached in almost 1s using 
the confocal port and recovery was measured in the wide-field. Stacks of 
nine images 0.5µm apart were collected every 3s.
VII.2.3.1.1 Image processing
The fluorescence intensity recovery was automatically tracked in 3D. 
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A small  parallelepiped  of  dimension  1x1x1.5  µm placed  at  the  most 
intense pixel  of  the region of  bleach was measured over time with a 
macro  written  for  ImageJ  (Rasband,  W.S.,  ImageJ,  U.  S.  National 
Institutes of Health, Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/, 
1997-2009). In the transcription spot FRAP experiments the post-bleach 
value was taken at the 5s time point, when the diffusion component of 
the recovery is expected to be already at equilibrium, and was set to 
zero.
VII.2.3.2 Confocal FRAP
Recovery curve shoved in figures  V.24,  V.28,  V.27,  V.29 and  VII.2 
were  obtained  with  the  confocal  LSM510  Meta  (Zeiss)  microscope. 
Images of 128x128 pixel (24.4x24.4 µm) and optical thickness of 1.5µm 
were  acquired  each  50ms  (V.24,  V.29 and  VII.2)  or  1.38s  (V.28 and 
V.27). A circle of 2.28µm diameter was bleached in less than 100ms.
VII.2.3.2.1 Image processing
Images  were  analyzed  with  ImageJ  (Rasband,  W.S.,  ImageJ,  U.  S. 
National  Institutes  of  Health,  Bethesda,  Maryland,  USA, 
http://rsb.info.nih.gov/ij/,  1997-2009).  When  a  transcription  spot  was 
bleached the “SpotTracker” plug-in [Sage et al., 2005] was used to track 
it in 2D and a macro was created to measure the fluorescence intensity 
in a circle of 1.14µm diameter at the center of the spot.
VII.2.3.3 Time lapse
Data in figures V.23 and V.22 were obtained from pictures acquired 
101
with the DMIRB (Leica) microscope. Stacks of 21 images 0.5µm apart 
were collected every 3min in figure V.23 and every 1h in figure V.22.
VII.2.3.3.1 Image processing
The  stacks  were  deconvolved  with  the  ImageJ  (Rasband,  W.S., 
ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://rsb.info.nih.gov/ij/,  1997-2009) plug-in “Iterative Deconvolve 3D” 
using an experimental PSF and successively maximally projected. The 
transcription spot was tracked with the “SpotTracker” plug-in  [Sage et
al., 2005] and a macro was used to measure the fluorescence intensity in 
a circle of 1.14µm diameter at the center of the spot.
VII.3 Curve Fitting
For the mathematical analysis of the data experimental normalized 
recovery curves from 10 to 20 cells were averaged.
To fit the Linear plus Exponential model, equation  13, a C++ code 
was  written  and  the  Chi-square  was  minimized  with  the 
multidimensional  minimization  routine  of  the  Gnu  Scientific  Library 
[GSL].
To  fit  Sprague  equations,  equations  4,  10,  18,  19 and  the  two 
independent binding site solution, a C++ code was written and the Chi-
square was minimized with the multidimensional minimization routine of 
the Gnu Scientific Library  [GSL]. To solve the equations the numerical 
inverse  Laplace  transform  was  computed  by  Euler  summation  as 
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proposed by  Yu Wei,  that  translated  the  algorithm in  C++ from the 
original in Abate et al.  [Abate, 1996], and the complex Bessel function 
library  was  obtained  from Jean-Pierre  Moreau  (http://pagesperso-
orange.fr/jean-pierre.moreau/c_bessel.html).
To fit the the simplified Sprague reaction-dominant solution, equation 
14, the R Nonlinear Least Squares (nls) function was used [R-project].
To develop Transcription Wave model, equation  17 and  20, and the 
Monte Carlo simulation, C++ codes were written based on GSL library 
[GSL]and when necessary previously described codes were used.
VII.4 MS2-G/YFP-nls
VII.4.1 Binding efficiency and U3
The  MS2  binding  efficiency  to  its  specific  19  nucleotides  RNA 
sequence  is  very  high.  In  vitro  the  mean  life  of  this  binding  is 
approximately 6h [Johansson et al., 1998]. To obtain an estimate for the 
rate of exchange of the MS2-G/YFP-nls protein on its target site in our 
system, we used an abundant non-coding RNA, U3. A single MS2 site 
was inserted in the apical loop of the rat U3B.7 gene. U3 is synthesized 
in the nucleoplasm and accumulates in nucleoli, where it plays essential 
functions during ribosomal RNA biogenesis [Kass et al., 1990]. It is also 
know that a fraction of the protein associated with U3 exchange slowly 
between  nucleoli  and  nucleoplasm  [Phair  and  Misteli,  2000].  When 
103
nucleoli  of  cells  expressing  only  MS2-G/YFP-
nls were bleached, fluorescence recovery was 
nearly  complete  within  seconds.  In  striking 
contrast,  when  nucleoli  of  cells  expressing 
both U3-MS2 and MS2-G/YFP-nls  (Fig.  VII.1) 
were  bleached,  only  a  fraction  of  the 
fluorescence was recovered, even after 10 min 
[Boireau  et  al.,  2007].  This  indicated  that  a  part  of  U3-MS2  was 
immobile and that bleached MS2-GFP-nls molecules stayed stably bound 
to the RNA.
VII.4.2 Nuclear MS2-G/YFP-nls diffusion
FRAP  experiments  on  nuclear  MS2-EYFP-nls  didn't  show  any 
substantial difference on kinetic properties of the protein in the two cell 
line HOS or U2OS.
HOS_B3 cells were tansfected 
with MS2-EYFP-nls but not with 
the viral transactivator Tat, and 
a circle  of  1.1µm was bleached 
in  the  nucleus.  The  recovery 
curve obtained, normalized as in 
equation  8,  was  initially  fitted 
with  the  Sprague  model  for 
single  binding  site  (Equation 
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Figure  VII.1:  Exo1 
transfected with U3
Figure  VII.2:  MS2-YFP-nls  recovery  curve  in 
the nucleoplasm.
10,Fig. VII.2). Since the results suggest that the low diffusion coefficient 
value can reflects an effective diffusion condition, we fitted the curve 
also  with  the  two  independent  binding  site  version  of  this  model 
[Sprague et al., 2004], and we obtained a more reasonable value for the 
diffusion  coefficient,  13  µm²/s.  The  results  of  the  two  model  are 
summarized in table 5. It is possible to speculate that one binding site is 
the aspecifing binding of the MS2 protein with RNAs in the nucleus and 
the second is specific for nls, the nuclear localization signal.
n binding D [µm²/s] τd1 [s] τb1 [s] τd2 [s] τb2 [s]
I 2.4 333 77 / /
II 13 20 4.7 0.6 0.4
Table 5: MS2-EYFP-nls FRAP in the nucleoplasm
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